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The chemistry of heterocycles has always been the major area of research for 
organic chemists owing to their wide spectrum of biological and pharmacological 
activities shown by them. Steroids too belong to same category and thus became a 
matter of paramount interest in recent past due to the hjoldgical activities associated 
with such molecules. This still continues to be a fascinating field worldwide. Our 
laboratory is concerned mainly with the synthesis of steroidal compounds and their 
identification by chemical and spectral studies, a number of reports dealing with the 
preparation of heterosteroids have appeared from our laboratories. The work 
embodied in this thesis describes the synthesis of heterosteroids, which are expected 
to be medicinally important. The whole work is divided into five chapters namely, 
Chapter-1 : Steroidal pyrazoles 
Chapter-2 : Steroidal pyrazolines 
Chapter-3 : Steroidal oxazoles 
Chapter-4 : Steroidal mercapto diazolines 
Chapter-5 : Antimicrobial activity of synthesized compounds 
The results are summarized below. 
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Chapter-1 
Steroidal pyrazoles 
In the recent past, the synthesis of steroidal pyrazole derivatives have attracted 
attention of organic chemists because of the interesting physiological activity and 
profound endocrinological interest associated with them. With this realization, some 
papers appeared dealing with synthesis of pyrozolosteroids. This prompted us to 
undertake the work in this area. We subjected some easily accessible steroidal 
tosylhydrazones such as 5 a-cholestan^-one tosylhydrazone (I), 3/?-acetoxy-5a-
cholestan-6-one tosylhydrazone (II) and 3/2-chloro-5or-cholestan-6-one 
tosylhydrazone (III) to the reaction with Vilsmeir reagent (POCI3-DMF) and 
obtained 5 -formyl-5or-cholestan [6,7-c] pyrazole (IV), 5 -formyl-3/?-acetoxy-5ar-
cholestan [6,7-c] pyrazole (V) and 5-formyl-3y3-chloro-5or-cholestan [6,7-c] 
pyrazole (VI) respectively. The products obtained have been characterized on the 
basis of their elemental analysis and spectral (IR, 'H-NMR, 13C-NMR and MS) 
studies. 
C«H 8n17 
POClyDMF 
N-NHTs 
C8Hn 
N NH 
X 
( I )H 
(II) AcO 
(III) CI 
X 
(IV) H 
(V) AcO 
(VI) CI 
L&&Z & 
00 
Chapter-2 
Steroidal pyrazolines 
Pyrazoline derivatives are important electron rich nitrogen heterocycles which play 
an important role in the diverse biological activities. These nitrogen heterocycles 
widely occur in nature in the form of alkaloids, vitamins, pigments and as 
constituents of plant and animal cells. Substituted pyrazolines have significant 
importance due to their wide spread pharmacological properties such as anti-
carcinogenic, anti-diabetic, anti-inflammatory, DP-IV inhibitors, anti-tumour and 
anti-parkinsonian. The above pharmaceutical interest and the continuation of our 
previous work encouraged us to synthesize some substituted steroidal pyrazolines. 
The substrates selected for initial studies include cholest-5-en-7-one (VII), 3/?-
acetoxycholest-5-en-7-one (VIII) and 3/?-chlorocholest-5-en-7-one (IX). The 
products obtained have been characterized on the basis of their elemental analysis 
and spectral (IR, 'H-NMR, 13C-NMR, MS) studies. 
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Chapter-3 
Steroidal oxazoles 
Oxazole derivatives are important heterocycles with oxygen and nitrogen separated 
by one carbon atom. The oxazoles are important structural units, which are present 
in a wide variety of biologically active natural products as well as in useful synthetic 
intermediates. Oxazoles are also common structural motifs in nature originating 
from post-translational modifications of serine and threonine residues in peptides. 
Oxazole derivatives also found their wide application as scintillating materials. 
Substituted oxazoles were recognized as intermediates for the synthesis of 
antibiotics and used as azadienes in Diel's-Alder reactions. Motivated by these 
biological and therapeutics studies a successful attempt is made to synthesize 
steroidal oxazoles in convenient one pot method. For this purpose 5a-cholestan-6-
one (XIII), 3/?-acetoxy-5a-cholestan-6-one (XIV) and 3/?-chloro-5 a-cholestan-6-one 
(XV) were allowed to react with thiourea in presence of iodine in absolute ethanol. 
The structures of the products have been characterized on the basis of their 
elemental analysis and spectral (IR, 'H-NMR, 13C-NMR and MS) studies. 
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Chapter-4 
Steroidal mercapto diazoline 
Thiourea and urea have been used as purification agents for the effluent of organic 
and inorganic, industrial, agricultural and mining wastes. These compounds were 
also known to possess anti-diabetic activity. A few compounds of thiourea have 
showed bactericidal, fungicidal, herbicidal and algicidal activities. It was described 
that 5-[n'-(carboxamidino) alkyl]-isothiourea act as radiation protector in 
mammalian skin. Some other thiourea derivatives such as O-allylthioureido benzoic 
acid also showed radioprotective effect to the phytohormones and in the yeast 
Schizosaccharomyces prombe. This has inculcated a great interest to synthesize 
steroidal heterocycles bearing diazolidine thione moiety, which may show enhanced 
biological activity. 
3/?-Hydroxy-5,6/?-dibromo-5a-cholestane (XIX), 3/?-acetoxy-5,6/?-dibromo-5«-
cholestane (XX) and 3/?-chloro-5,6/?-dibromo-5a-cholestane (XXI) on treatment 
with thiourea in absolute ethanol gave 3/?-hydroxy-5a-cholestan-2'-mercapto- [6, 5-
d]-l', 3'-diazoline (XXII), 3y?-acetoxy-5a-cholestan-2'-mercapto [6, 5-d]-l', 3'-
diazoline (XXIII) and 3/?-chloro-5a-cholestan-2'-mercapto- [6, 5-d]-l', 3'-diazoline 
(XXIV). The products obtained have been characterized on the basis of their 
elemental analysis and spectral (IR, 'H-NMR, 13C-NMR, MS) studies. 
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Chapter-5 
Antimicrobial activity of synthesized compounds 
The in vitro antibacterial activity of the synthesized compounds X-XII was carried 
out against B. subtilis, S. pyogenes, S. aureus, P. aeruginosa, K. pneumoniae and E. 
coli. Antibacterial activities of 2'-amino-5a-cholest-6-eno [6,5-t/] oxazole 
derivatives XVI-XVIII were tested using the bacterial cultures of Gram-positive 
bacteria B. subtilis, S. aureus, S. pyogenes and Gram-negative bacteria P. 
aeruginosa, S. typhimurium, E. coli and fungal cultures of Candida albicans, 
Candida glabrata, Penicillium spp., Fusarium oxyporium, Aspergillus niger by the 
disk diffusion method and then the minimum inhibitory concentration (MIC) of all 
the compounds were determined. These newly synthesized compounds XXII-XXIV 
were evaluated in vitro against B. subtilis, P. aeruginosa andE. coli. 
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The chemistry of heterocycles has always been the major area of research for 
organic chemists owing to their wide spectrum of biological and pharmacological 
activities shown by them. Steroids too belong to same category and thus became a 
matter of paramount interest in recent past due to the biological activities associated 
with such molecules. This still continues to be a fascinating field worldwide. Our 
laboratory is concerned mainly with the synthesis of steroidal compounds and their 
identification by chemical and spectral studies, a number of reports dealing with the 
preparation of heterosteroids have appeared from our laboratories. The work 
embodied in this thesis describes the synthesis of heterosteroids, which are expected 
to be medicinally important. The whole work is divided into five chapters namely, 
Chapter-1 : Steroidal pyrazoles 
Chapter-2 : Steroidal pyrazolines 
Chapter-3 : Steroidal oxazoles 
Chapter-4 : Steroidal mercapto diazolines 
Chapter-5 : Antimicrobial activity of synthesized compounds 
The results are summarized below. 
Chapter-1 
Steroidal pyrazoles 
In the recent past, the synthesis of steroidal pyrazole derivatives have attracted 
attention of organic chemists because of the interesting physiological activity and 
profound endocrinological interest associated with them. With this realization, some 
papers appeared dealing with synthesis of pyrozolosteroids. This prompted us to 
undertake the work in this area. We subjected some easily accessible steroidal 
tosylhydrazones such as 5a-cholestan-6-one tosylhydrazone (I), 3y9-acetoxy-5a-
cholestan-6-one tosylhydrazone (II) and S/J-chloro-So'-cholestan^-one 
tosylhydrazone (III) to the reaction with Vilsmeir reagent (POCI3-DMF) and 
obtained 5-formyl-5or-cholestan [6,7-c] pyrazole (IV), 5-formyl-3/?-acetoxy-5or-
cholestan [6,7-c] pyrazole (V) and 5 -formyl-3/?-chloro-5cr-cholestan [6,7-c] 
pyrazole (VI) respectively. The products obtained have been characterized on the 
basis of their elemental analysis and spectral (IR, ' H-NMR, 13C-NMR and MS) 
studies. 
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Chapter-2 
Steroidal pyrazolines 
Pyrazoline derivatives are important electron rich nitrogen heterocycles which play 
an important role in the diverse biological activities. These nitrogen heterocycles 
widely occur in nature in the form of alkaloids, vitamins, pigments and as 
constituents of plant and animal cells. Substituted pyrazolines have significant 
importance due to their wide spread pharmacological properties such as anti-
carcinogenic, anti-diabetic, anti-inflammatory, DP-IV inhibitors, anti-tumour and 
anti-parkinsonian. The above pharmaceutical interest and the continuation of our 
previous work encouraged us to synthesize some substituted steroidal pyrazolines. 
The substrates selected for initial studies include cholest-5-en-7-one (VII), 3/?-
acetoxycholest-5-en-7-one (VIII) and 3/?-chlorocholest-5-en-7-one (IX). The 
products obtained have been characterized on the basis of their elemental analysis 
13/ 
and spectral (IR, 'H-NMR, lJC-NMR, MS) studies 
CsH 
TSC/NaOC?Hs 
Reflux 
8 n17 
NH2 
X 
(VII) H 
(VIII) AcO 
(IX) CI 
X 
(X) H 
(XI) AcO 
(XII) CI 
t\ii\ 
Chapter-3 
Steroidal oxazoles 
Oxazole derivatives are important heterocycles with oxygen and nitrogen separated 
by one carbon atom. The oxazoles are important structural units, which are present 
in a wide variety of biologically active natural products as well as in useful synthetic 
intermediates. Oxazoles are also common structural motifs in nature originating 
from post-translational modifications of serine and threonine residues in peptides. 
Oxazole derivatives also found their wide application as scintillating materials. 
Substituted oxazoles were recognized as intermediates for the synthesis of 
antibiotics and used as azadienes in Diel's-Alder reactions. Motivated by these 
biological and therapeutics studies a successful attempt is made to synthesize 
steroidal oxazoles in convenient one pot method. For this purpose 5<ar-cholestan-6-
one (XIII), 3/?-acetoxy-5 a-cholestan-6-one (XIV) and 3/?-chloro-5 or-cholestan-6-one 
(XV) were allowed to react with thiourea in presence of iodine in absolute ethanol. 
The structures of the products have been characterized on the basis of their 
elemental analysis and spectral (IR, 'H-NMR, 13C-NMR and MS) studies. 
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Chapter-4 
Steroidal mercapto diazoline 
Thiourea and urea have been used as purification agents for the effluent of organic 
and inorganic, industrial, agricultural and mining wastes. These compounds were 
also known to possess anti-diabetic activity. A few compounds of thiourea have 
showed bactericidal, fungicidal, herbicidal and algicidal activities. It was described 
that ^-[^-(carboxamidino) alkylj-isothiourea act as radiation protector in 
mammalian skin. Some other thiourea derivatives such as O-allylthioureido benzoic 
acid also showed radioprotective effect to the phytohormones and in the yeast 
Schizosaccharomyces prombe. This has inculcated a great interest to synthesize 
steroidal heterocycles bearing diazolidine thione moiety, which may show enhanced 
biological activity. 
3/?-Hydroxy-5,6/?-dibromo-5a-cholestane (XIX), 3/?-acetoxy-5,6/?-dibromo-5a-
cholestane (XX) and 3/?-chloro-5,6/?-dibromo-5a-cholestane (XXI) on treatment 
with thiourea in absolute ethanol gave 3/?-hydroxy-5a-cholestan-2'-mercapto- [6, 5-
d]-T, 3'-diazoline (XXII), 3/?-acetoxy-5a-cholestan-2'-mercapto [6, 5-dj-T, 3'-
diazoline (XXIII) and 3/?-chloro-5a-cholestan-2'-mercapto- [6, 5-d]-l', 3'-diazoline 
(XXIV). The products obtained have been characterized on the basis of their 
elemental analysis and spectral (IR, 'H-NMR, 13C-NMR, MS) studies. 
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Chapter-5 
Antimicrobial activity of synthesized compounds 
The in vitro antibacterial activity of the synthesized compounds X-XII was carried 
out against B. subtilis, S. pyogenes, S. aureus, P. aeruginosa, K. pneumoniae and E. 
coli. Antibacterial activities of 2'-amino-5a-cholest-6-eno [6,5-d] oxazole 
derivatives XVI-XVIII were tested using the bacterial cultures of Gram-positive 
bacteria B. subtilis, S. aureus, S. pyogenes and Gram-negative bacteria P. 
aeruginosa, S. typhimurium, E. coli and fungal cultures of Candida albicans, 
Candida glabrata, Penicillium spp., Fusarium oxyporium, Aspergillius niger by the 
disk diffusion method and then the minimum inhibitory concentration (MIC) of all 
the compounds were determined. These newly synthesized compounds XXII-XXIV 
were evaluated in vitro against B. subtilis, P. aeruginosa and E. coli. 
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For the last seventy years the chemistry of steroids has provided one of the most 
interesting and thoroughly explored areas for organic chemists. The dramatic expansion 
of steroidal chemistry came with the discovery of steroidal hormones. The discovery of 
several biologically active steroids with their wide application in therapy have 
brought about an increasing interest. The synthetic modification of naturally 
occurring steroids with the hope of improving pharmacological essentialities has 
resulted in the preparation and discovery of a number of diverse 
pharmacologically active, potent, highly specific commercially important 
therapeutic agents. The physiological activity of steroidal hormones depends on a 
number of factors. Among those of primary importance are stereochemistry and overall 
shape of the molecule. Even a fundamental change in the steroid skeleton should alter the 
stereochemistry at least to some extent. Thus during the last decade the major efforts of 
the chemists were directed towards the modification in the structure of steroids in order to 
enhance their non-hormonal activity and to increase the selectivity of certain biologically 
active compounds. Our laboratory, concerned mainly with the synthesis of steroidal 
compounds and their identification by chemical and spectral studies, has reported the 
preparation of a number of heterosteroids. 
In the present work an attempt has been made to synthesize some modified 
steroids of biological interest such as pyrazoles, pyrazolines and oxazoles. The final 
chapter deals with antimicrobial activity of the synthesized compounds. The 
characterization of these compounds has been achieved by chemical and spectral methods 
employing UV, IR, 'H-NMR, 13C-NMR and Mass. 
1 
CHAPTER-1 
Steroidal(Pyrazofes 
TheoreticaC 
fctfkbW* 
The pyrazole system (1), consists of a doubly unsaturated five membered ring with two 
adjacent nitrogen atoms. Knorr,1"2 first synthesized compounds containing this system in 
1883 by the reaction of ethylacetoactate with phenyl hydrazine, which yielded 1-phenyl-
3-methyl-5-pyrazolone (2). Knorr3 introduced the name pyrazole for these compounds to 
denote that the nucleus was derived from pyrrole by replacement of a carbon by nitrogen. 
They synthesized many members of this class and systematically investigated their 
properties. 
O ^  
HC C--CH3 
c 
,N 
I 
C6H5 
(2) 
Survey of literature has revealed that till 1930s very little, had been done for the 
synthesis of steroidal pyrazole derivatives. Probably the first steroidal pyrazole was 
reported in 1938 by Ruzicka et alA and only a single derivative, cholest-4-eno [3.2-c] 
pyrazole-5-carboxylic acid (3), was mentioned. 
(3) 
After a considerable span of time, much attention has been paid by a number of 
organic chemists towards the synthesis of several pyrazolosteroids. The effect on 
endocrinological activity produced by the fusion of a pyrazole ring to a steroid nucleus 
has prompted us to investigate such type of compounds. The compounds containing 
2 
pyrazole ring system can be synthesized by different routes and here we have 
summarized only important examples, as below. 
Kira et al5 reported that treatment of acetophenone phenylhydrazone (4-7) with 
two moles of DMF-POCI3 in DMF at 70-80°C for six hours gave immonium perchlorate 
8. Alkaline hydrolysis of 8, afforded 1, 3-diarylpyrazole-4-carboxaldehyde (9-12). 
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(12) /7-C6H4N02 C6H5 
Kira et al6 synthesized 3-substituted pyrazole-4-carboxaldehyde (19-24) by the 
reaction of acetophenone semicarbazones (13-18), with two moles of DMF-POCI3 in 
DMF. 
CH3-C-R 
OHC-7 T - R 
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(13) C6H5 (19) 
R 
C6H5 
3 
(14) o-CH30-C6H4 
(15) p-N02-C6H4 
(16) m-N02-C6H4 
(17) 2-thienyl 
(18) CH3 
(20) 
(21) 
(22) 
(23) 
(24) 
o-CH30-C6H4 
p-N02-C6H4 
m-N02-C6H4 
2-thienyl 
CH3 
Bavatenko and coworkers7 reported substituted pyrazoles (29-32) by cyclizing 
aryl hydrazones (25-28), under Vilsmeier conditions. 
O 
N-NHAr 
Ar 
(25) C6H5 
(26) 4-FC6H4 
(27) 4-CH3C6H4 
(28) 4-CH3OC6H4 
DMF - POCl3 
(29) 
(30) 
(31) 
(32) 
C6H5 
4-F C6H4 
4-CH3C6H4 
4-CH3OC6H4 
3,5-Disubstituted pyrazoles (35-38) were obtained by the reaction of gem-
dichlorocyclopropylacetates (33-34) with 4-equiv of hydrazine or phenylhydrazine at 
room temperature while metacyclophane (40) and its isomer (41) were obtained from 1-
acetoxy 2,2-dichlorobicyclo [10.1.0] tridecane (39) with hydrazine under same 
condition. 
O 
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E 2 
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0C-CH3 
C6H 6 J 1 5 
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(37) CH3 
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+ 
(49%) 
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CgHs H 
H C6H5 
Q H 5 C6H5 
(-5%) 
(41) 
: 
Pawar and Borse reported 4-n-alkyisubstituded pyrazoles (48-53), from 
phenylhydrazones (42-45), semicarbazones (46) and azines of 2-n-acyl-5-chlorophenoles 
(47) by monoformylation and cyclization by using one mole of the Vilsmeier-Haack 
reagent (DMF-POCI3). 
(42) 
(43) 
(44) 
(45) 
(46) 
(47) 
CH2-R 
DMF/ POCI3 
OH 
R1 
N. 
R1 
CH3 
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R^  
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Ph 
Ph 
(CH2)2CH3 Ph 
(CH2)2CH3 Ph 
CH3 CONH2 
OH 
CH3 
/ 
c2Hj 
-ci 
5 
JO Sridhar reported pyrazole-4-carboxaldehyde (62-69), by the reaction of hydrazones of 
aliphatic and aromatic methylketones (54-61), with Viismeier reagent. They also studied 
the reactivity of hydrazones of y3-ketoesters towards Viismeier reagent, both by 
conventional and microwave methods. 
COOCH2R 
DMF - POCI3 
Reflux or MWI 
COOCH2R 
(54) 
(55) 
(56) 
(57) 
(58) 
(59) 
(60) 
(61) 
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E: 
H 
H 
N02 
N02 
H 
N02 
H 
(62) 
(63) 
(64) 
(65) 
(66) 
(67) 
R 
CH3 
CH3 
CH3 
CH3 
Q H 5 
C6H5 
K 
H 
CH3 
H 
CH3 
CH3 
CH3 
K 
H 
H 
N02 
N02 
H 
N02 
p-CIC6H4 CH3 N02 
(68) P-CIQH4 CH3 H 
(69) p-ClCel-U CH3 N02 
Borrell et al synthesized pyrazoles library by using Merrifield resin as a solid-
phase supporting to an hydroxyacetophenone (70), Vilsmeier-Haack formylation on 
methyl group and cyclization with substituted hydrazine to afford 4-hydroxy-benzoyl-l-
substituted pyrazoles (72-76). 
6 
(70) 
CHO 
(71) 
NH2NHR' 
R 
(72) 
(73) 
(74) 
(75) 
(76) 
^ H \ R l 
R" 
H 
C6H5 
C2H5 
C2H4OH 
C2H4CN 
J2 Dhar and Bhat reported 3, 5-diphenyl-lH-pyrozoles (80), from chalcones (77), 
by the action of hydrazine hydrate on chalcone-epoxide (78), followed by simultaneous 
dehydration in presence of catalytic amount of cone. H2SO4 in acetic acid. 
H202/ OH' 
(78) 
(77) 
H2NNH2.H20 
(79) 
(78) 
(80) 
Kidwai and coworkers13 used microwave irradiation and synthesized 4-methyl-2-
[3'-substituted-phenyl-4'-formylpyrozolyl] quinoline (85-88), by the reaction of 
hydrazones of methylquinoline (81-84), with DMF and POCI3 under microwave 
irradiation of 3-4 min. 
7 
CH3 
R 
~N^ NHN=C-
I 
CH3 
(81) 
(82) 
(83) 
(84) 
R 
H 
4-CI 
4-CH3 
4-Br 
DMF/POCI3 
(85b 
(86) 
(87) 
(88) 
R 
H 
4-CI 
4-CH3 
4-Br 
3-Aryl-4-formyl-l[3(2-chlorophenyl)-l, 8-naphthyridin-2-yl] pyrozoles (93-96) were 
yielded when hydrazones (89-92) were subjected to microwave irradiation in the 
presence of Vilsmeier-Haack reagent. 
Ck 
% ^ N > vfHN=( 2—As 
CH3 
Ar 
(89) C6H5 
(90) 4-CH3C6H4 
(91) 4-CH3OC6H4 
(92) 4-C1C 6H4 
POCI3 -DMF/ SD2 
MWI 
^ N' *N' ^N N 
Ar 
(93) 
(94) 
(95) 
(96) 
CHO 
Ar 
C6H5 
4-CH3C6H4 
4-CH3OC6H4 
4-ClC6H4 
8 
Condensation of 2-hydrazino-3-(4-methoxyphenyl)-l,8-naphthyridine (97) with 
aryhdeneacetophenones (98-99), in glacial acetic acid under microwave irradiation 
afforded the corresponding 2-(3,5-diaryl-2-pyrazolin-l-yl)-3-(4-methoxy-phenyl)-l,8-
naphthyridines (100-101), which on oxidation with CAN in methanol under MWI 
furnished 2-(3,5-diarylpyrazol-1 -yl)-3-(4-methoxyphenyl)-l ,8-naphthyridines (102-
103). 15 
N W NH-NH, 
(97) 
O 
II CH3COOH 
+ Ar ' -CH=CH-C-Ar - >-
Ar' Ar 
(98) C6H5 C6H5 
(99) C6H5 P-CH3OQH4 
MWI 
OCH3 
Ar' Ar 
(100) C6H5 C6H5 
(101) C6H5 p-CH3OC6H4 
Ar' Ar 
(102) C6H5 C6H5 
(103) C6H5 p-CH3OC6H4 
Giacomelli et al. '6 prepared a variety of 3-aryl-4-formyl pyrazoles (110-115) by 
reaction of 1 molar equivalent of hydrazones of the ketones (104-109), with 2,4,6-
trichloro-[l,3,5] triazine (TCT) in DMF at room temperature and subsequent 
neutralization with Na2C03 (15%). 
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R 
N TCT/ DMF 
HN 
i 
R1 
(104) 
(105) 
(106) 
(107) 
(108) 
(109) 
R1 
CeHs 
C6H5 
C6H5 
C6H5 
C6H5 
C6H5 
R 
C6H5 
0-CH3C6H4 
m-CH3C6H4 
P-CH3C6H4 
p-HOC6H4 
P-C1C6H4 
o=c 
Na2C03 
(110) 
(111) 
(112) 
(113) 
(114) 
(115) 
R' 
C6H5 
C6H5 
C6H5 
C6H5 
C6H5 
C6H5 
R2 
C6H5 
O-CH3C6H4 
m-CH3C6H4 
p-CH3C6H4 
p-HOC6H4 
P-CIQH4 
3-Aryl-l-(3-phenyloxiran-2-yl)-prop-2-en-l-ones (116-121) on treatment with 
tosylhydrazine under acid catalysis in THF gave 3-(2-arylvinyl)-5-hydroxy-5-phenyl-l-
tosyl-lH-pyrazoles (122-127)17, with 58-65% yield. Additionally, 3-(2-arylvinyl)-5-
phenyl-1-tosyl-lH-pyrazoles (128-133), were also isolated with 7-12% yield by 
chromatography after crystallization of the major products. 
Ar Ar 
Ar TsNHNH, 
(116) 
(117) 
(118) 
(119) 
(120) 
(121) 
Ar 
Ph 
4-Cl-C6H4 
3-Cl-C6ri4 
4-F-C6H4 
4-Br-C6H4 
4-N02-C6H4 
H+, THF 
Ph 
HO 
N-
I 
Ts 
Ar 
Ph (122) 
(123) 4-Cl-C6H4 
(124) 3-Cl-C6H4 
(125) 4-F-C6H4 
(126) 4-Br-C6H4 
(127) 4-N02-C6H4 
+ 
Ph 
(128) 
(129) 
(130) 
(131) 
(132) 
(133) 
I 
T s 
,N 
Ar 
Ph 
4-Cl-C6H4 
3-Cl-C6H4 
4-F-C6H4 
4-Br-C6H4 
4-N02-C6H4 
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Perumal and Selvi synthesized 4-ethoxy-4H-benzopyrano [4, 3-c] prazoles (140-
145), from o-hydroxyacetophenone-2,4-dinitro phenylhydrazone (134-139), under the 
Vilsmeier condition. 
NO, 
NO, 
DMF/ PQC13 
RT, 4 hr 
R R' R R' 
(134) 
(135) 
(136) 
(137) 
(138) 
(139) 
H 
H 
H 
H 
H 
OCH3 
H 
OCH3 
CH3 
CI 
OH 
H 
(140) 
(141) 
(142) 
(143) 
(144) 
(145) 
H 
H 
H 
H 
H 
OCH3 
H 
OCH3 
CH3 
CI 
OH 
H 
Substituted hydrazones of 2-acetyl-3-phenylindoles (146-148) treated with 2 
moles of Vilsmeier-Haack reagent followed by alkaline hydrolysis furnished 2-(4-formyl-
3-pyrazolyl)-3-phenylindoles (149-151). 19 
(146) 
(147) 
(148) 
R 
R 
CH3 
CH3 
CH3 
N 
H 
R1 
H 
C6H5 
NH 
S02C6H4CH3(4") 
DMF/pock 
(149) 
(150) 
(151) 
R 
CH3 
CH3 
CH3 
CHO 
R1 
R1 
H 
C6H5 
S02C6H4CH3(4-) 
11 
Singh et al. reported the synthesis of pyrazolo [3, 2-c] cholest-4-ene (153) and 
[T H]-5'-(methlthio)pyrazolo [3,2-c] cholest-4-ene (155) from 2-ethoxymethylene-4-
cholesten-3-one (152) and bis(methylthio)methylene cholest-4-en-3-one (154), 
respectively, by the action of hydrazine hydrate and refluxing in ethanol. 
(152) (153) 
(154) (155) 
Clinton et al.21 reported that treatment of 17a-methylandrostan-17/?-oi-3-one 
(156) with ethylformate and sodium methoxide gave the 2-hydroxymethylene derivatives 
(157) which on condensation with hydrazine gave 17/?-hydroxy-17a-methylandrostano 
[3, 2-c] pyrazole (158). Similar treatment of 2-hydroxymethyIene-17«-methylandrost-4-
en-17/?-ol-3-one (159), furnished hydroxy methylene-17tf-methylandrost-4-eno [3,2-c] 
pyrazole (160). In someway, the homologous 17/?-hydroxy-17a-methylandrost-4, 6-
dieno [3, 2-c] pyrazole (162), was obtained from 161. 
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HOHC. 
*• HN 
(156) (157) (158) 
HOH 
(159) 
NH2NH2 HN 
(160) 
HOH 
(161) 
NH,NH, 
(162) 
Hirschmann and coworkers22 also reported several [3, 2-c] pyrazoles related to 
Cortisol, 16«-methylcortisol and 4, 5a-dihydrocortisol. The Cortisol side chain of 163 was 
protected by formation of the bismethylenedioxy (DMD) derivative (164), for the 
synthesis of pyrazoles related to 16«-mefhylcortisol. The compound 164 was allowed to 
react with ethylformate in benzene in the presence of sodium hydride to give the 2-
hydroxymethylene derivative (165). The compound 165 was subjected for condensation 
with hydrazine, phenylhydrazine, N-substituted and N-alkylated hydrazine to yield the 
[3,2-c] pyrazoles (166, 167, 169, 162, 163, 177-179), which are summarized in charts 1 
and 2. 
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Chart-1 
HO 
CH2OH 
= o 
OH CH, 
H2CO 
-v 
HO" 
O 
(163) (164) (165) 
PhNHNH, 
NH2 
I 
NH2 
Ph-N 
(166) 
N 
N-
H 
y 
^ 
(167) 
HCK CH.CT 
(165) (168) 
PhNHNH2 
(169) 
14 
Chart -2 
(170) 
(171) 
(165,168) R-N 
R 
CH3 
CH2CH2OH 
(172) 
(173) 
R 
CH3 
CH2CH2OH 
(165,168) 
(174) 
(175) 
(176) 
F 
CI 
H 
(177) 
(178) 
(179) 
F 
CI 
H 
Berbalk and his coworkers23 in 1982 reported that the epoxyandrostane (180-182) 
underwent formolysis to give phenyl acetylandrostane (183-185) which on further 
cyclocondensation with hydrazine afforded androsteno-pyrazoles (186-188). 
15 
(186) 
(187) 
(188) 
R 
OAc 
OH 
Er 
H 
H 
R R ^ o 
16 
Bonn and Dodson24 carried out the hydrazine reduction of 16a, 17-epoxy-
pregnenolone (189) to obtain 3/?-hydroxyandrost-5-eno [16, 17-C]-5'-methylpyrazole 
(190) along with the two isomeric allylic alcohols, 5, 17 [20]-(Cw)-pregnadiene-3/3-, 16a-
diol (191) and 5, 17 [20]-(/rara)-pregnadiene-3y9, 16a-diol (192). 
HO 
(189) 
HCK" 
(190) 
NH 
H O ^ 
(191) 
H3C\ 
HCK" 
(192) 
The reaction of 20-ethoxy-21-formyl-17/?-pregna-14, 20-diene (193), with 
hydroxylamine and hydrazine hydrate afforded 17y#-(3-pyrazolyl)-3/?-acetoxy-5a-
androst-14-ene (194), which was subjected to N-acetylation followed by epoxidation with 
monoperphthahc acid to give the a-epoxy product (195). The compound 195 on alkaline 
hydrolysis, resulted in the formation of the desired 17/?-(3-pyrazolyl)-14a-15a-
expoxyandrostane (196)."' 
Scu. 9 * 
17 
AcO 
Eto^ y H 
AcCT^ 
H 
> 2 6 Green et air reported the synthesis of a number of steroidal pyrazoles and 
pyrazolines in the androstane series. The addition of triethylamine to a mixture of the 
compound 197 and benzoylchloride phenylhydrazone led to the 65% yield of 3/?-
acetoxypregna-5-en-20-one [16a, 17o-d] - 1 ' , 3'-diphenyl-2'-pyrazoline (199), as 
predicted. 
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AcO AcO 
(197) 
(198) 
R 
COCH3 
CN 
(199) 
(200) 
R 
COCH3 
CN 
Similarly, the addition of diphenyl nitrilimine to 3/?-acetoxy-17-cyanoandrosta-5. 
16-diene (198), took place in the same regiochemical sense to yield 3/?-acetoxy-11/3-
cyanoandrost-5-eno [16a, 17a-d]-l', 3'-diphenyl-2'-pyrazoline (200). The pyrolesis of 
200 at 290 °C resulted in the formation of 3/?-acetoxyandrost-5-eno [16, 17-d]-
diphenylpyrazole (201). 
AcO 
Ph 
-HCN 
A 290° 
AcO 
(200) (201) 
Laitonjam and coworkers27 synthesized substituted steroidal [3,2-c] pyrazoles 
(204-205) and steroidal [17,16-c] pyrazoles (208-209), by the reaction of 2-
ethoxymethylene-4-cholesten-3-one (202), 2-bis(methylthio)methylene cholest-4-en-3-one 
(203). 3/?-hydroxy-16-ethoxymethylen-5-androsten-17-one (206) or 3/?-hydroxy-16-
bis(methylthio) methylene-5-androsten-17-one (207), with hydrazine hydrate and 
refluxed for 3 h. 
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(202) 
(203) 
C$H\7 
R R1 
H OC2H5 
SCH3 SCH3 
NH2NH2 
_ . N _ 
(204) 
(205) 
R 
H 
SCH3 
R R' 
(206) H OC2H5 
(207) SCH3 SCH3 
R 
(208) H 
(209) SCH3 
Peseke et al." reported that the treatment of 3/?-acetoxy-16-[bis (methylthio) 
methyIene]-5-androst-5-en-17-one (210) with hydrazine hydrate and methylhydrazine 
afforded the 5'-methyrthio-pyrazolo [A1, 3': 16,17] androst-5-en-3/?-ols (211-212). 
SCH3 
SCH3 
AcCT^ AcO 
(210) (211) 
(212) 
R 
H 
CH3 
R 
N - N 
SCH3 
20 M N ^ J J 
(Discussion 
As a part of our continuing effort towards the synthesis of modified steroids, which are 
expected to be biologically active, the fusion of heterocycles to steroids often led to a 
change in physiological activities or appearance of new interesting biological behaviour. 
Thus, several steroidal heterocycles have been obtained exhibiting activity potential 
inhibitors of cytochrome P450 enzyme aromatage30'31, with their subsequent clinical 
application in the treatment of estrogen dependent breast cancer. 
Pyrazoles constitute a class of compounds associated with wide spread popularity 
in the field of medicine '34 and agrochemistry", as evident from number of reports 
covering their preparations and uses. Many of these, such as steroidal pyrazoles, were 
found to possess antimicrobial, anti-inflammatory, hypotensive, hypocholesterolemic and 
diuretic activities.35"43 
The therapeutic importance of these steroidal pyrazoles20 and study of reaction of 
DMF-POCI3 which has dual role of reagent as well as solvent, with simple 
tosylhydrazones giving pyrazoles encouraged us to make similar studies with steroidal 
tosylhydrazones. The substrates selected for initial studies include 5or-cholestan-6-one 
tosylhydrazone (213)44, 3/?-acetoxy-5or-cholestan-6-one tosylhydrazone (214)44 and 1/3-
chloro-5or-cholestan-6-one tosylhydrazone (215).45 The products obtained have been 
characterized on the basis of their elemental analysis and spectral (IR, 'H-NMR, 13C-
NMR and MS) studies. 
N-NH-Ts 
(213) H 
(214) AcO 
(215) CI 
21 
Reaction of 5cr-cholestan-6-one tosylhydrazone (213) with POCb and DMF. 
The tosylhydrazone (213) in DMF was allowed to react with POCI3 under ice-
cold conditions. The orange yellow precipitate thus obtained was filtered, washed with 
water, dried and then recrystallized from methanol to give compound 216, m.p. 99 °C. 
POCI3- DMF 
N-NH Ts 
/CHO 
N NH 
(213) (216) 
Characterization of the compound, m.p. 99 °C as 5-formyl-5a-cholestan [6,7-c] 
pyrazole (216): 
The elemental analysis of the compound corresponded to the molecular formula 
C29H46N20. Its IR spectrum showed a band at 3404 cm"1 which could be assigned to NH 
group and another band at 1708 may be ascribed to -CHO. A band at 1595 cm" was 
attributed to (C=N), other bands at 1625 and 1378 cm"1 were due to (C=C) and (C-N) 
respectively. These values supported the presence of pyrazole moiety46 in the product 
molecule. The structure 216 was well supported by its *H NMR spectrum which 
displayed two singlets integrating for one proton each at S 8.09 and 8.8 (exchangeable 
with D2O) indicating the presence of aldehyde and NH proton respectively. Other 
prominent peaks for angular and side chain methyl protons were observed at S 1.13, 0.92, 
0.85, and 0.65. The absence of any signal for aromatic protons in the NMR spectrum 
suggested the removal of tosyl group. The structure of compound has been further 
supported by its mass spectrum (M+ 438). Moreover, the 13C NMR of the compound 
displayed characteristic signals at CI' (152.41), CHO (212.84), C3 (25.20), C7 (129.12). 
Remaining carbon atoms are seen in accordance to the cholestane series. 
On the basis of foregoing discussion and mechanism proposed (Scheme- 1), this 
compound can best be characterized as 5-formyl-5«'-cho]estan [6, 7-c] pyrazole (216). 
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Reaction of 3/?-acetoxy-5a-cholestan-6-one tosylhydrazone (214) with POCI3 and 
DMF. 
The tosylhydrazone 214 in DMF was allowed to react with POCl3 under cold 
condition. The reaction mixture after usual workup and removal of solvent gave an oily 
product 217, which was failed to crystallize. 
AcO 
POCI3-DMF 
AcO 
N-NHTs N NH 
(214) (217) 
Characterization of the oily compound as 5-formyl-3/?-acetoxy-5a-cholestan [6,7-c] 
pyrazole (217): 
The elemental analysis of the compound corresponded to the molecular formula 
C31H48N2O3. Its IR spectrum showed a band at 3427 cm"1 which could be assigned to NH 
group and another band at 1710 cm"1 may be ascribed to -CHO. The IR spectrum of the 
compound exhibited strong absorption bands at 1730 and 1282 cm" indicating the 
presence of acetate group, a band at 1595 cm"1 was due to (C=N), and other bands for 
(C=C) and (C-N) stretchings appeared at 1623 and 1378 cm"1 respectively. These values 
supported the presence of pyrazole moiety in the product molecule. The structure 217 was 
well supported by its 'H NMR spectrum which displayed two singlets integrating for one 
proton each at S 8.03 and 8.73 (exchangeable with D2O) indicating the presence of 
aldehyde and NH proton respectively. A broad multiplet was observed at 8 4.6 (W;/2 = 16 
Hz, axial) which could be assigned to C3-0C proton and the acetate protons appeared at 
S 2.02 as a sharp singlet. Other prominent peaks for angular and side chain methyl 
protons were observed at S 1.11, 0.87, 0.75, and 0.66. The absence of any signal for 
aromatic protons in the NMR spectrum suggested the removal of tosyl group. The 
structure of the compound has been further supported by its mass spectrum (M+ 496). 
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Moreover, the 13C NMR spectrum of the compound showed structures revealing signals 
at CI' (151.15), CHO (212), C3 (72.41), C6 (136.41), C7 (128.7). Remaining carbon 
atoms are seen in accordance to the cholestane series. 
On the basis of above studies and its analogy with earlier compound 216, this can 
best be characterized as 5'-formyl-3/?-acetoxy-5a-cholestan [6, 7-c] pyrazole (217). 
Reaction of 3/?-chloro-5a-cholestan-6-one tosylhydrazone (215) with POCU and 
DMF. 
The steroidal tosylhydrazone (215) in DMF was allowed to react with POCl3 
under cold condition. The reaction mixture after usual work up and removal of solvent 
gave an oily product 218. All attempts to crystallize this product were unsuccessful. 
POCI3-DMF 
N-NH-Ts N NH 
(215) (218) 
Characterization of the oily compound as 5-formyl-3y9-chloro-5cr-cholestan [6,7-c] 
pyrazole (218): 
The elemental analysis of the compound corresponded to the molecular formula 
C29H45N2OCI (Beilstein positive). Its IR spectrum showed a band at 3428 cm"1 which 
could be assigned to NH group and another band at 1709 cm"1 may be ascribed to -CHO. 
Other important bands appeared at 1596, 1625, 1378 and 768 cm"1. The band at 1596 
cm"1 was for (C=N), a band at 1625 cm"1 was due to (C=C) and other bands at 1378 and 
768 cm"1 indicated the presence of (C-N) and (C-Cl) group respectively. These values 
supported the presence of pyrazole moiety in the molecule. The structure 218 was well 
supported by its 'H NMR spectrum which displayed two singlets integrating for one 
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proton each at S 8.10 and 8.7 (exchangeable with D2O) indicating the presence of 
aldehyde and NH proton respectively. A broad multiplet (W1/2 = 17 Hz, axial) was 
observed at <5 4.12 which could be assigned to C3- a proton. Other prominent peaks for 
angular and side chain methyl protons were observed at S 1.13, 0.87, 0.7 and 0.66.The 
absence of any signal for aromatic protons in the NMR spectrum suggested the removal 
of tosyl group. The structure of compound 218 has been further supported by its mass 
spectrum (M+ 472/474). Moreover, the 13C NMR of the compound displayed 
characteristic signals at CI' (153.14), CHO (212), C3 (59.16), C6 (138.2), C7 (120.2). 
Remaining carbon atoms are seen in accordance to the cholestane series. 
The above data led to the structure of compound, as 5-formyl-3/?-chloro-5a-
cholestan [6, 7-c] pyrazole (218). 
Formation of steroidal pyrazoles 216, 217 and 218 under the condition case may 
be shown according to the proposed mechanism (Scheme 1). In the light of available 
mechanism,1618 this may be taken as tentative in the absence of studies to establish the 
mechanism of reaction. 
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o 
Me2N-(i:-H + P0C1, -*• Me2N=C<"j ~0P0C12 
H 
H 
CT N-NH—Ts 
CH-NMe2 
: N - N H - T s 
^=CH-NMe2 
J X 
C-NMe 
N - T s :N N - T s 
(216,217,218) 
X = H, OAc, CI 
Scheme-1 
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Melting points were determined on a Kofler apparatus and are uncorrected. The IR 
spectra were recorded on KBr pellets with Pye Unicam SP3-100 spectrophotometer and 
its values are given in cm"1. !H NMR spectra were measured in CDCI3 on a Bruker DRX-
300 spectrometer at 300 MHz and 13C NMR spectra at 100 MHz, with TMS as internal 
standard and the values are given in ppm (<5). Mass spectra were recorded on a JEOL SX 
102/DA-6000 mass spectrometer using Argon/Xenon as the FAB gas. Thin layer 
chromatography (TLC) plates were coated with silica gel G and exposed to iodine 
vapours to check the homogeneity as well as the progress of reaction. Petroleum ether 
refers to a fraction of b.p. 60-80 °C. Sodium sulphate (anhydrous) was used as a drying 
agent. 
ChoIest-5-ene: 
3/?-Chlorocholest-5-ene (10 g) was dissolved in warm amyl alcohol (230 mL) and 
sodium metal (20 g) was added in small portions to the solution with continuous stirring 
over a period of 8 h. The reaction mixture was warmed occasionally. When all sodium 
metal was dissolved, the reaction mixture was poured into water, acidified with dilute 
hydrochloric acid and allowed to stand overnight. A white crystalline solid thus obtained 
was filtered under suction and washed thoroughly with water and air dried. 
Recrystallization of the crude material from acetone gave cholest-5-ene in cubes (8.3 g) 
m.p. 93 °C (reported m.p. 89 -91.2 °C).47 
6-NitrochoIest-5-ene: 
A suspension of finely powdered cholest-5-ene (6 g) in glacial acetic acid (50 
mL) was stirred at room temperature for 5 min. and nitric acid (15 mL, d, 1.52) was 
rapidly added followed by the addition of sodium nitrite (3 g) and the stirring was 
continued for further 2 h. The temperature of the reaction mixture was controlled between 
20-25 °C by external cooling. The reaction mixture was then poured into ice cooled 
water. A yellow solid thus obtained was filtered under suction, washed thoroughly with 
water and air dried. Recrystallization from ethanol furnished 6-nitrocholest-5-ene (4.5 g), 
m.p. 119 -120 °C (reported m.p. 120 -121 °C).48 
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5cr-Cholestan-6-one: 
6-NitrochoIest-5-ene (6 g) was dissolved in glacial acetic acid (120 mL) by 
heating and to this solution zinc dust (12 g) was gradually added in small portions with 
shaking. After the initial exothermic reaction had subsided, the suspension was heated 
under reflux for 4 h and water (12 mL) was added during the course of reaction. The 
solution was then filtered and the residue was washed with two (10 mL) portions of warm 
acetic acid. To the filtrate, a few mL of water was added till turbidity developed and it 
was allowed to stand overnight at room temperature. The crystalline material thus 
separated was filtered under suction and washed thoroughly with water in order to 
remove zinc acetate. The organic solid was air dried and then recrystallized from ethanol 
(3.6 g), m.p. 96 -98 °C (reported m.p. 98 -100 °C).49 
5a-Cholestan-6-one tosylhydrazone (213): 
5a-Cholestan-6-one (1 g) was dissolved in warm glacial acetic acid (10 mL). 
Then solution was cooled and /7-toulenesulphonyl hydrazide (1 g) was added with 
shaking. After about 15 min, a crystalline material began to separate and the reaction 
mixture was allowed to stand overnight at room temperature. The solid material was 
filtered, washed with ethanol and air dried. Recrystallization from ether gave 
tosylhydrazone as fine needles (213) (1.1 g), m.p. 165 °C (reported m.p. 165 °C).44 
Reaction of 5or-cholestan-6-one tosylhydrazone (213) with POCb and DMF: 5-
formyl-Sa-cholestan [6,7-c]pyrazole (216): 
To a solution of 5a-cholestan-6-one tosylhydrazone (213) (0.44 g) in DMF (6 
mL) under ice cold condition, POCI3 (0.5 mL) was added at such a rate that temperature 
of the reaction vessel did not exceed 10 °C with constant stirring. After the complete 
addition the reaction mixture was allowed to attain room temperature, however, the 
stirring was continued for an additional period of 3 h. Progress of reaction was followed 
by using TLC. 
The reaction mixture was poured onto crushed ice and left overnight at 5 °C. It 
was extracted with ether. The ethereal layer was washed with water, sodium bicarbonate 
solution (5%) and again with water, dried over anhydrous sodium sulphate. Removal of the 
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solvent gave an oil which was crystallized from methanol to give 5 -formyI-5tf-cholestan [6, 
7-c] pyrazole (216), m.p. 99 °C, yield 70 %. 
Analysis found: C, 79.42; H, 10.48; N, 6.36 
C29H46N2O requires: C, 79.45; H, 10.50; N, 6.39%. 
IR (KBr): vmax 3404 (-NH), 1708 (-CHO), 1625 (C=C), 1595 (C=N), 1378 cm"1 (C-N). 
'H-NMR (CDCb): 6 8.8s (1H, NH, exchangeable with D20), 8.09s (1H, CHO), 1.13s 
(3H, C10-CH3), 0.65s (3H, C13-CH3), 0.92, 0.85 (other side chain methyl protons). 
I3C-NMR (CDC13): 8 CI' (152.41), CHO (212.84), C3 (25.20), C6 (140.16), C7 (129.12), 
C8 (32.83), C9 (51.68), C10 (35.96), C18 (11.86), C19 (17.33), C25 (28.08), C26 
(21.78), C27 (22.64) 
MS:w/z438(M+) 
3/?-AcetoxychoIest-5-ene: 
A mixture of cholesterol (50 g), pyridine (75 mL freshly distilled over KOH) and 
freshly distilled acetic anhydride (50 mL) was heated on water bath for 2 h. The resulting 
brown solution was poured into crushed ice water mixture with stirring. A light brown 
solid thus obtained was filtered under suction, washed with water until free from pyridine 
and air dried. The crude product on crystallization from acetone gave pure 3/?-acetoxy 
cholest-5-ene (45 g), m.p. 113 -114 °C (reported m.p. 115-116 °C).53 
3/?-Acetoxy-6-nitrochoIest-5-ene: 
To a cooled mixture of 3/?-acetoxycholest-5-ene (10 g) and nitric acid (250 mL; d, 
1.42), sodium nitrite (10 g) was gradually added over a period of 45 min. with continuous 
stirring. Slight cooling was also affected during the course of reaction and stirring was 
continued for additional 2 h. and then cold water (350 mL) was added to the reaction 
mixture. The solid material thus separated was extracted with ether and the ethereal layer 
was washed with water, sodium bicarbonate solution (5%) (until washing was pink) and 
water and dried over anhydrous sodium sulphate. Removal of the solvent provided 
compound as an oil which was crystallized from methanol to give 3/?-acetoxy-6-
nitrocholest-5-ene (7.0 g), m.p. 104 °C (reported m.p. 102-104 °C).54 
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3/?-Acetoxy-5a-choIestan-6-one: 
3/?-Acetoxy-6-nitrocholest-5-ene (6 g) was dissolved in hot glacial acetic acid 
(250 mL) and zinc dust (12 g) was added in small portions with shaking. The suspension 
was heated under reflux for 4 h. and water (12 mL) was added during the course of 
reaction. Zinc dust was removed by filtration and the filtrate was diluted with large 
excess of water. Usual work up of the reaction mixture afforded the ketone, which was 
crystallized from methanol (3.9 g), m.p. 128 °C (reported m.p. 127-128 °C).55 
3/?-Acetoxy-5a-cholestan-6-one tosylhydrazone (214). 
3/3-Acetoxy-5or-cholestan-6-one (1 g) was dissolved in warm glacial acetic acid 
(10 mL). Then solution was cooled and p-toulenesulphonyl hydrazide (1 g) was added 
with shaking. After about 15 min, a crystalline material began to separate and the reaction 
mixture was allowed to stand overnight at room temperature. The solid material was 
filtered, washed with ethanol and air dried. Recrystallization from ether gave 
tosylhydrazone as fine needles (217) (1.1 g), m.p. 185 °C (reported m.p. 188 °C).44 
Reaction of 3/?-acetoxy-5a-cholestan-6-one tosylhydrazone (214) with POCI3 and 
DMF: 5-formyl-3P-acetoxy-5a-cholestan [6,7-c]pyrazole (217): 
To a solution of 3/2-acetoxy-5ar-cholestan-6-one tosylhydrazone (214) (0.44 g) in 
DMF (6 mL) under ice cold condition, POCI3 (0.5 mL) was added at such a rate that 
temperature of the reaction vessel did not exceed 10 °C with constant stirring. After the 
complete addition the reaction mixture was allowed to attain room temperature, however, 
the stirring was continued for an additional period of 3 h. Progress of reaction was 
followed by TLC. 
The reaction mixture was poured onto crushed ice and left overnight at 5 °C. It 
was extracted with ether. The ethereal layer was washed with water, sodium bicarbonate 
solution (5%), again with water and dried over anhydrous sodium sulphate. Evaporation of 
the solvent yielded an oily product 5-formyl-3/?-acetoxy-5a-cholestan [6, 7-c] pyrazole 
(217), yield 60 %. 
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Analysis found: C, 74.97; H, 9.64; N, 5.61 
C31H48N2O3 requires: C, 75.0; H, 9.67; N, 5.64%. 
IR (Neat): vmax3427 (NH), 1730 and 1282 (CH3COO), 1710 (-CHO), 1623 (C=C), 1595 
(ON), 1378cm"'(C-N), 
'H-NMR (CDCI3): S 8.73s (1H, NH, exchangeable with D20), 8.03s (IH, CHO), 4.6m 
(1H, C3-ocH, W1/2=16 Hz), 2.02s (3H, CH3COO), 1.11s (3H, C10-CH3), 0.66s (3H, C,3-
CH3), 0.87, 0.75 (other methyl protons). 
13C-NMR (CDCI3): S CI' (151.15), CHO (212), CH3COO (171.61), C3 (72.41), C6 
(136.41), C7 (128.7), C8 (35.72), C9 (51.04), C10 (35.08), C18 (11.83), C19 (17.10), 
C25 (28.07), C26 (22.63), C27 (22.63) 
MS: m/z 496 (M+) 
3/?-ChIorochoIest-5-ene: 
Freshly purified thionyl chloride (75 mL) was added gradually to cholesterol (100 
g) at room temperature. A vigorous reaction ensued with the evolution of gaseous 
products. When the reaction slackened, the mixture was gently heated at the temperature 
of 50-60 °C on a water bath for 1 h and then poured onto crushed ice-water mixture with 
stirring. The yellow solid thus obtained was filtered under suction and washed several 
times with ice cooled water and air dried. Recrystallization of crude product from acetone 
gave 3/J-chlorocholest-5-ene (94 g), m.p. 95-96 °C (reported m.p. 96-97 °C).50 It gave 
positive Beilstein test and a yellow colour with tetra-nitromethane in chloroform. 
3/?-ChIoro-6-nitrocholest-5-ene: 
To a well stirred mixture of 3/?-chlorocholest-5-ene (14 g), glacial acetic acid 
(100 mL) and nitric acid (28 mL, d, 1.52) at temperature below 20 °C, was added sodium 
nitrite (3.0 g) gradually over a period of 2 h. After complete addition of sodium nitrite, 
the mixture was further stirred for an additional period of 1 h. Ice cooled water (200 mL) 
was added and the yellowish solid thus separated was filtered and air dried. The desired 
product was recrystallized from methanol as needles (8.9 g) m.p. 151-152 °C (reported 
m.p. 153 °C).51 
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(References 
3/?-Chloro-5#-cholestan-6-one: 
A solution of 3/?-chloro-6-nitrocholest-5-ene (12 g) and glacial acetic acid (240 
mL) was heated just to get a clear solution. The zinc dust (24 g) was added gradually in 
small portions with constant shaking. The suspension was heated under reflux for 4 h. 
and water (24 mL) was added at regular intervals during the course of reaction. The hot 
solution was poured into ice-cold water. The organic matter was extracted with ether and 
ethereal solution was washed successively with water, sodium bicarbonate solution (5 %) 
and again with water and dried over anhydrous sodium sulphate. Evaporation of the 
solvent furnished the ketone as an oil which was crystallized from methanol (8.7 g), m.p. 
128-129 °C (reported m.p. 129 °C).52 
3/?-Chloro-5a-choIestan-6-one tosyihydrazone (215). 
3/?-Chloro-5«-cholestan-6-one (1 g) was dissolved in warm glacial acetic acid (10 
mL). Then solution was cooled and /?-toulenesulphonyl hydrazide (1 g) was added with 
shaking. After about 15 min, a crystalline material began to separate and the reaction 
mixture was allowed to stand overnight at room temperature. The solid material was 
filtered washed with ethanol and air dried. Recrystallization from ether gave 
tosyihydrazone as fine needles (218) (1.1 g), m.p. 167 °C (reported m.p. 167 °C).45 
Reaction of 3yS-chloro-5«-cholestan-6-one tosyihydrazone (215) with POCl3 and 
DMF: 5'-formyl-3P-chloro-5a-cholestan[6,7-c]pyrazole (218): 
To a solution of 3y3-chloro-5«-cholestan-6-one tosyihydrazone (215) (0.44 g) in 
DMF (6 mL) under ice cold condition, POCI3 (0.5 mL) was added at such a rate that 
temperature of the reaction vessel did not exceed 10 °C with constant stirring. After the 
complete addition the reaction mixture was allowed to attain room temperature, however, 
the stirring was continued for an additional 3 h. Progress of reaction was monitored by 
TLC. 
The reaction mixture was poured onto crushed ice and left overnight at 5 °C. It 
was extracted with ether. The ethereal layer was washed with water, sodium bicarbonate 
solution (5%) and again with water then dried over anhydrous sodium sulphate. Evaporation 
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of the solvent yielded an oily product 5 -formyl-3/?-chloro-5#-cholestan [6, 7-c] pyrazole 
(218), yield 55 %. 
Beilstein positive 
Analysis found: C, 73.69; H, 9.51; N, 5.90 
C29H45N2OCI requires: C, 73.72; H, 9.53; N, 5.93 %. 
IR (Neat): vmax 3428 (-NH), 1709 (-CHO), 1625 (C=C), 1596 (ON), 1378 (C-N), 768 
cm-'(C-Cl). 
'H-NMR (CDCI3): d 8.7s (IH, NH, exchangeable with D20), 8.10s (IH, CHO), 4.12m 
(IH, C3-«H, Wi/a 17 Hz), 1.13s (3H, C10-CH3), 0.66s (3H, C13-CH3), 0.87, 0.78 (other 
methyl protons). 
13C-NMR (CDCI3): 5 CI' (153.14), CHO (212), C3 (59.16), C6 (138.2), C7 (120.2), C8 
(32.58), C9 (51.51), C10 (35.79), C18 (11.82), C19 (16.98), C25 (29.81), C26 (22.65), 
C27 (21.98) 
MS: m/z 4121414 (M+). 
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CHAFTER-2 
Steroidal<PyrazoCines 

The pyrazoline ring (1) system consists of a monounsaturated five membered ring 
containing two adjacent nitrogen atoms. 
,N 
N' 
H 
(1) 
Since many drugs and dyes contain the pyrazoline nucleus, the class has been widely 
studied and the field continues to be active today. Assad1 synthesized pyrazolines and 
pyrazoles from /7-hydoxy acetophenone using NH2NH2 in acetic acid and checked their 
anti-microbial properties. Tokes et al2 synthesized 3-benzoyl-4-phenyl-2-pyrazolines by 
the reaction of chalcones with diazomethane. Doyl et al.3 carried out the dipolar addition 
of diazocarbonyl compounds to a, fi- unsaturated esters and nitriles in the presence of 
pyridine, which resulted in the production of 2- pyrazolines. 
Chincholkar and Jamode4 synthesized 4-aroyl-substituted pyrazolines (2) [R1 = H, 
Me, R2 = H, MeO, R3 = H, MeO, 3, 4-methylenedioxyl] by cyclocondesation of 3-
1 9 \ 
aroylflavanones (3) with PhNHNH2 and 4- aroyl substituted pyrazoles (4) [R , R , R as 
above] from corresponding 3- aroylflavones. 
OH 
(2) 
f ll 
, 0 . 
o 
CO / \ R2 
OH 
\_J~1 N. 
f~\ y-tf 
-co 
1/ / ' " N / V V - R 3 
R1 Ph N \ /—K 
(3) (4) 
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Kokade and Jamode5 prepared pyrazolines (7) [R1 = H, Br, R2 = H, Me, R3 = C6H5, 
C6H4OMe] by cyclocondensation of PhNHNH2 with chalcones 5 or flavanones 6 by 
refluxing in DMSO. 
COC}l=CH—R 
(5) (6) 
(7) 
2'-Hydroxy-4'-acetamidochalcones on reaction with NH2OH in ethanol provided 
isoxazoline (8) [X = 0] while with NF^NHband PhNHNH2, respective pyrazolines (8) [X 
= NH and NPh] were obtained.6 
NHAc 
Halo and hydroxyaryl pyrazolines were synthesized by Latif et al.1'8 using the NH2NH2 
as the reagent. They also obtained 1, 3, 5-triaryl pyrazolines from 3, 4-
dichloroacetophenone, which were dehydrogenated by tetrachloro-O- benzoquinone to 
pyrazoles, which inhibited aflatoxion production by A. flavus. 
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1 _ The dichalcones (9) [R = H, F, CI, Br, MeO] were cyclized with R'NHNH2 [R1 = H, Me, 
Ph] to give the dipyrazolines (10). 
4-RC6H4COCH=CH 
4-RQH,-
CH=CHCOC6H4R-4 
C6H4R-4 
Cycloaddition of CH2N2 to RC6H4S02 CH : CH [R = H, 4-Br, 4-Cl, 2- Me, 4-Me] in 
the presence of Et3N gave 3-aryl sulfonyl-2-pyrazoline10. Sachchar and Singh 
cyclized chalcone derivatives (11) [R = 2-furyl, 2- thienyl, 2-pyridyl, R1 = H, Me, CI, 
OH] with PhNHNH2 and NH2OH to give the pyrazolines and isoxazolines (12) [X = 
NPh, O] respectively, which were tested for bactericidal and fungicidal activities. 
R' R' 
(12) 
Epoxy ketones (13) [R = CI, N02] reacted with NH2NH2, PhNHNH2 and NH2NHCONH2 
to give pyrazolines (14) [X = NH, NPh, NNHCONH2], while with NH2OH they gave 
isoxazolines (14)12 [X =0]. 
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R-
O 
CO -CHMe2 
Me2HC 
(13) 
(14) 
Cyclization of ketones (15) with NH2NH2, PhNHNH2 and NH2OH produced pyrazolines 
and isoxalines (16)13 [R = Ph, 4-MeOC6H4, 4- CIQH4, 4-02NC6H4, PhCH: CH; X = 
NAc, NPh, OJ respectively. 
J4 Some 3-aroyl-4-aryl-2-pyrazolines were prepared by condensation of a, /^-unsaturated 
ketones with diazomethane in Et3N. 
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.15 Kumar and Husain prepared N-[4-(acetyl/phenyl-5-aryl pyrazoline-3-yl) phenyl] 
aryl sulfonamides (18) [R =H, Me, R1 = H, CI, OMe, Me, N0 2 , R2 = Ac, Ph] by 
cyclization of (17) [R and R1 as defined for 18] with NH2NH2 and PhNHNH2 
R- S02NH- -COCH=CH- R 
R- S07NH-
(17) 
(18) 
w 
N - N 
R2 
• R 
4-(3, 4-Me2C6H3S03) C6H4COCH: CHC6H4R-4 [R = H, OMe, Br, CI] Reacted with 
NH2NH2. PhNHNH2 and NH2OH to give pyrazolines and isoxazolines (19)'6 [X = NH, 
NPh, O], respectively. 
S 0 3 \ ^ \ ^ ^R 
(19) 
\17 3-(4, 4-Dimethy-2-piperidon-6-yl) methyl-2-pyrzolines (21)" [R = H, Me, CI, R 
Me, Ph] were prepared by cyclocondensation of the butanone 20 with R'NHNH2. 
H, 
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Me. Me 
H 
CH2COCH=CH 
(20) 
Me., Me 
O ^ N ' CH 
H '-J 
N 
R1 
(21) 
R 
R 
Treatment of dimethylchromans (22) [R - R3 = H, Me, OMe] with NH2NH2 yielded 3-
aryl-dimethyl pyrazolines (23).18 
R 
RJ O R
J
 N NH 
(22) (23) 
Agrawal19 reported the formation of pyrazoles (24) [R1 = H, Me, R2, R3 = H, OMe] by 
the treatment of pyrazolines (25) with Mn02 in CHC13. Pyrazolines (25) were obtained 
by heating chalcones with NH2NH2 in ethanol. 
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\\ 
N-NH 
(24) 
N-NH 
(25) 
Some 1, 3, 5-tripheny]-3- pyrazolines derivatives (26)20 [R1 = H, OMe, CI] were 
synthesized by heating 3- and 4-hydroxy chalcone derivatives with PhNHNFh using 
acetic acid as catalyst. The synthesized compounds were found to possess antifungal 
activity. Mishriky et al21 reported the synthesis of l-acetyl-3,5-diaryl-A2- pyrazolines 
(27) [R1 = Ph, anisyl, HO(MeO)C6H3, R2 - C12C6H3, FC6H4J by heating chalcones with 
NH2NH2 in AcOH. The formation of aflatoxion by Aspergillus flavus was inhibited by 
27. 
R^  
R 
N 
Ph 
OH 
\ 
K1 
R1 
V 
N 
(26) 
N 
Ac 
(27) 
Chalcones (28) [R1 = Ph, 02NC6H4, HOC6H0, anisyl, Me2NC6H4] were heated with 
NH2NH2 in acetic acid and with PhNHNH2 to give pyrazolines (29)22 [R2 = Ac, Ph,]. 
They showed usefulness as bactericides and fungicides. 
Mev Mev 
COCH=CHR 
(28) (29) 
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Cinnamoylbenzofurans (30) [R1 = H, Me, R2 = Ph, anisyl, dimethoxyphenyl] were heated 
with NH2NH2 in AcOH to give pyrazolines (31)23 which showed bactericidal activity. 
OMe 
COCH=CHR'£ 
OMe 
(30) 
Tabakovic and Rapic heated coumarin chalcones (32) [R = Ph, tolyl, aminophenyl] 
with R2NHNH2 [R2 = H, Me, Ph, 02NC6H4] in AcOH to give pyrazolines (33). 
COCH=CHR 
(32) (33) 
Malov el al25 reported the formation of 5-hydrazinyl-2- pyrazolines (34) by the reaction 
of diketones MeCOCH2COR [R = Me, Pr, CH2CHMe2] with hydrazides R'CONHNH2 
[R1 = Me2CH, Me2CHCH2, Me3C, Ph] in ethanol. 
„R 
Me 
R'CONHNH N' 
.N 
COR1 
(34) 
.:26 Shingare and Siddiqui*" synthesized arylsulfonyl pyrazolines and isoxazolines (35) [X = 
NH, NPh. O; R = H, Me, R1 = H, Me, CI, R2 = substituted Ph, heteroaryl] by the 
cyclocondesation of chalcones with NH2NH2, PhNHNH2 orNH2OH. 
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R K 
~X R" 
(35) 
so2-
2 
R1 
Maib and Jerzmanowaska" carried out the reaction of chromones (36) [R, R = H, Me] 
with H2NNHCSNH2 to give pyrazolines (37) [R2= H, Me] and pyrazoles (38) [R3 = H, 
»4 r>5 CSNH2 R , R3 = H, Me]. 
<X .R 
(36) 
R\ NHNHC(S)NKb 
\ NC(S)NH2 
N 
OH 
(37) 
RDx R" 
^ NR 3 
OH 
(38) 
In another study chalcone 3, 4-Cl (Me)-C6H3CH: C: CHC6H4N02-4 was allowed to react 
with NH2NHR [R = H, PH] to give pyrazolines (39)28 [same R]. Pyrazolines (40)29 [R 
=Ac, COEt, CHO, Me, R1, R3 = H, OMe. R2 = OH, OMe, Me] were prepared by 
cyclizing propenones (41) with NH2NH2 and ROH or with MeNHNH2. 
\\ / — M c 
02h 
R 
(39) 
0 2 N ' x 0 
(40) 
0 2 N o ' 
-CH=CHCO-
(41) 
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Roda et al prepared 5-aryl-l-phenyl-3-(3-isopropyl-4-hydroxy-6-methylphenyl)-2-
pyrazolines (42) [R = H. 2-, 3-, 4-OH, 2- and 4-C1, 3- and 4-N02, 4-OMe, 4-NMe2 etc.] 
by cyclocondensation of the chalcones with PhNHNH2. Pyrazolines (43)31 [R = OMe, CI, 
R1 = 3, 4-OCH20, 4-OMe, R2 = H, Ph, Bz, S02Ph etc] were prepared by the reaction of 
4-RC6H4COCH: CHC6H4R' with R2NHNH2. 
Me 
V^Q. -O-CcO, 
Ph 
(42) (43) 
Ankhiwala and Naik32 prepared pyrazolines (44) [R = H, 2-Br, 4-Me2N] by 
cyclocondensation reaction of PhNHNH2 with the corresponding RC6H4CH : 
CHCOC6H2(N02)(OBu)OH-5, 4, 2. l-Acetyl-3, 5-diphenyl-2- pyrazoline derivatives 
(45)33 [R = 2-, 3- or 4-OH, R1 = H, CI, OMe, R2 = H, Br) were prepared by the reaction 
of hydroxychalcone derivatives with NH2NH2 in AcOH. 
OH 
(44) (45) 
Holla et ali4 carried out the reaction of propynones (46) [R =H, Me] with R'CONHNH2 
[R1 = Ph, 4-CIC6H4, 2-HOC6H4, 2-naphthyloxymethyl], which furnished 2-pyrazoline 
(47). On acid catalyzed hydrolysis they were converted into the lH-pyrazoles (48). 
46 
(46) 
02N' 
02N' 
Ox 
"0' 
K 
N 
I 
COR 
(47) 
z\-N 
I 
COR 
(48) 
R1 
R' 
Sereya et al.35 synthesized 5-methylpyrazoline by reacting crotonaldehyde with NH2NH2. 
Hydrazine was refluxed with MeCH : CHCHO in ethanol to give l-(3-pyridyl carbonyl)-
5-methyl-2-pyrazoline36 which also showed cerebrovascular protective activity. 
Kleefeld and Dutzmann37 prepared 1, 3, 5-triphenyl-2-pyrazoline (49) by heating 
l-phenyl-3- (4-hydroxy phenyl)-2-propen- 1 -one and PhNHNH2 in AcOH. They were 
used for the control of Erysiphe graminis on barley. l-Methyl-3, 5-diphenyl-2-
pyrazoline derivatives (50)39 [R = 4-Me, 2-OMe, 4-OMe, 4-Cl, 4-F, 2-Br, 4-Br] were 
prepared by cyclocondensation of chalcones with MeNHNH2. 
47 
Ph 
(49) 
Kumar et ali9 synthesized pyrazolines (52) by cyclization of chalcones (51) [R = Me, 4-
MeC6H4, Ph, R1 = 2-MeO, 2-F, H, Li-Me2N, 2-OH] with NH2NH2 in acetic acid. The 
pyrazolines were found to possess anti-inflammatory activity. 
The cyclocondensation of PhCH : C(CHO)C(CHO) : CHPh with H2NHHR [R = H, Ph, 
4-02NC6H4, 2, 4-(02N)2C6H3] gave bipyrazolines (53), while with NH2OH gave 
biisoxazoline (54).40 
(50) 
CH 
48 
(54) 
.41 Upadhyay el air cyclized 4-PhS02NHQH4COCH : CHAr [Ar = Ph, 2-02NC6H4, 3-
ClCeRt, 2-hydroxy-l-naphthyl etc] with NH2NH2 / AcOH or PhNHNH2 to give 
pyrazolines (55) [R = Ac, Ph]. 
P h S 0 2 N R ^ ^ 
Pyrazolines (56)42 [R = H, Ph, Ar = 3-ClC6H4, 4-N02C6H4, 3, 4- (OCH20) C6H3], 
isoxazolines (57) and thioxopyrimidines (58) were prepared from chalcones (59) by 
condensation with H2NNHR, NH2OH and H2NCSNH2, respectively. 
Me Me 
N-NR 
// 
N - 0 
COC^CHAr 
49 
-43 Singh reported the condensation reaction of substituted thiazolidinones with PhCHO or 
p-anisaldehyde in the presence of NaOAc in AcOH to give phenyliminobenzylidene 
thiazolidinones (60) [R = Ph, R1 = H, Ph, R = 4- MeOC6H4, R1 = Ph], which on 
cyclization with hydrazines gave thiazolidinopyrazolines (61) [R = Ph, R1 = H, Ph, R = 
Ph, R - Ph, R1 = Ph, R2 = H, Ph, R - 4- MeOC6H4, R, = Ph, R2 =H]. 
PhN 
(61) 
Sonare and Doshi44 carried out the condensation of 2'-hydroxy-4'- methoxy chalcones 
(62) [R1 = OMe, R2 = H, R1 = R2 = H, R!R2 = OCH20] with NH2NH2 in ethanol to give 
lH-3-(2'-hydroxy-4'-methoxy)-5-substitited phenyl-2-pyrazolines (63) [R = H]. 
MeO, 
(62) 
Haggag et al.45 reported the preparation of IH-A2- pyrazolines (65) [R = F, R = R = H, 
R = R1 = Gl, R2 = H] from the reaction of propenones (64) with NH2NH2 in absolute 
ethanol. 
(64) (65) 
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Reaction of 1, 2, 3, 4-tetrahydronaphthaIene chalcones (66) [R = 4-Me2NH6H4, 4-
MeOC5H4, 3, 4, 5-(MeO)3 C6H2, 4-ClC6H4, 4-02NC6H4, 2- thienyl] with NH2NH2 in 
AcOH gave tetrahydronaphthyl-A2-pyrazolines (67).46 
XOCH=CHR 
(66) (67) 
N 
I 
C=0 
I 
Me 
Raut and Doshi47 reported pyrazolines (68) [R = Me, Ph, R1 = OMe, H] by the reaction of 
chalcones with NH2NH2 in ethanol. The chalcones on condensation with hydrazides of 
phenoxyacetic acid, p-chlorophenoxyacetic acid, a-napthoxyacetic acid and /?-
naphthoxyacetic acid yielded the corresponding pyrazolines (69)48 [R = Ph, 4-CIC3H4, R 
= Ph, 3-02NC6H4, 4-MeC6H4 etc]. 
COR 
N-N-COCH2OPh 
(68) (69) 
3-(Aroylethyl) sydnones and phenylhydrazine were heated in ethanol via an elimination, 
condensation and cyclization to give l-phenyl-3-aroyl-pyrazolines. l-Aryl-4, 6-
dimethyl pyrimidin-2 (lH)-ones (70) [R = H, Me, OMe] with NH2OH and AcNHNH2 led 
to isoxazolines and pyrazolines (71)5 [same R; X = O, NAc] respectively. 
Mex 
Me 
R—<v /) N y - Me ^ R — < \ />—NHCONH-
• N 
// 
X-N 
O 
(70) (71) 
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Compounds 72 and 73 were prepared by the reaction51 of araldehyde hydrazones and 
araldoximes with bifunctional olefins in presence of chloramine-T. 
a a 
Ph 
S02—Ph 
(72) 
S02— Ph 
(73) 
Kedar carried out the reaction of chalcones with hydrazine carboxamide 
monohydrochloride and obtained l-carboxamido-3, 5-diaryl-A -pyrazolines. The reaction 
of cyclopenta (hexa) nones with hydrazine and aryl hydrazines gave the corresponding 
azines, hydrazones and pyrazolines52. The condensation of 5- chloro-3-methyl-2-acetyl 
benzofuran with aromatic aldehydes in presence of alkali gave 2-cinnamoyl-5-chloro-3-
methylbenzofurans, which on further reaction with NH2NH2 furnished 5-aryl-3-(5-
chloro-3-methyl-2-benzofury)-lH-pyrazolines. Acetylation and benzoylation of these 
provided 1-acetyl and 1-benzoyl pyrazolines (74)53 [R = (un) substituted Ph, 2-furyl, R = 
Me, Ph]. 
N NCOR 
(74) 
Survey of the literature has revealed that very little attention till 1930s had been made 
about the synthesis of steroidal pyrazole derivatives. Probably the first steroidal pyrazole 
was reported by Ruzicka et al.54 in 1938. Only a single derivative, cholest-4-eno [3, 2-c] 
pyrazole-5'-carboxylic acid (75), was mentioned. 
52 
(75) 
After considerable span of time, much attention has been paid by a number of organic 
chemists towards the synthesis of several steroidal pyrazolines. The biological activity 
produced by the fusion of a pyrazoline ring to a steroid nucleus has prompted them to 
investigate such type of compounds. 
Kamernitskii55 carried out the cycloaddition of 3/?-acetoxypregna-5, 16-dien-20-
one with ^CHCCbEt which gave pregnenopyrazolines 76 and 77. 76 isomerized to 77 in 
the presence of acids. 
AcO 
CO,Et 
(76) 
Catsonlacos and Stassinopouloin56 prepared pregneno [20, 21-c] pyrazolines (79) by the 
reaction of benzylidenepregnenone (78) with RNHNH2 [R = Ph, 4-MeOC6H4] in the 
presence of HCl. The alkaline hydrolysis of the acetoxy group of 79 [R = Ph] followed 
by Oppenauer oxidation gave oxopregneno [20, 21-c] pyrazoline (80). 
53 
(78) (79) 
(80) 
Green et a/.37 synthesized steroidal [16a, 17a-d]-2'-pyrazolines (82) and [16, 17-d] 
pyrazoles (83). 3/?-Acetoxyandrostadienes (81) [R = MeCO] with PhCCl: NNHPh / Et3N 
gave steroidal pyrazoline (82). Similar cycloaddition reactions of 81 [R = AcO] gave 
androstenopyrazoles (83) [R = Ph, R1 = Ph,p-C1C6H4; R =p-ClC6H4, R1 = Ph]. 
(81) (82) (83) 
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Pregn-5-en-3/?-ol-20-one acetate condensed with 2-pyridine carboxyldehyde to give cis-
and trans-2 i -(2-pyridylmethylene) pregn-5-en-3/?-yl acetate, which cyclocondensed with 
PhNHNH2 to give pyrazoline (84).58 Alkaline hydrolysis of 84 followed by Oppenauer 
oxidation, gave pregneno [20, 21-e] pyrazole (85). 
(85) 
3-Oxo-/?-boswellic acid methyl ester was derivatized using different aromatic aldehydes 
yielding corresponding arylidene derivatives (86) [R = H, 3-OH, 3-NO2, 3, 4-(MeO)2]. 
Cyclization of 86 with NH2NH2 gave pyrazoline derivatives (87)59, which were found to 
possess anti-inflammatory and antiarthritic activity. 
55 
R-
Me ' I H 
C02Me 
(86) 
(87) 
Claisen condensation of 3/?-acetoxy and 3/?-chloroandrost 5-en-17-one with dimethyl 
carbonate gave the carbomethoxy androstenones (88) [R = OAc, CI] which cyclized with 
R'NHNH2 [R1 = H, Me, Ph] to give the androstenopyrazolines (89). Cyclization of 88 
with NH2OH gave the androstenoisoxazolines (90) 60 
56 
CO, Me 
(88) 
(89) 
,N 
"NR1 
O 
In another reaction, androst-5-en-17-one (91) with dimethyl oxalate afforded glyoxalate 
(92), which was cyclized with NH2NH2 and PhNHNPb to give androst-5-eno [17, 16-c] 
pyrazoles (93) [R = H, Ph] and with NH2OH it gave androst-5-eno [17, 16-c] isoxazole 
(94). 61 
AcO 
(91) 
O OH 
I 
C—C02Me 
(92) 
CO, Me 
(93) (94) 
C02Me 
Bratenko et at1 synthesized 1-aryl (heteryl)-3-[3-aryl (heteryl)-4 pyrazolyl] propenones 
(95) [R1 = Ph. R2 = Ph, 4-FC6H4, 4-ClC6H4, 4-BrC6H4, 4-EtC6H4, 4-MeOC6H4J by 
57 
condensation of 3-aryl(heteryl)-4-formylpyrazoles (96) [R1 = Ph, 2-thienyl, 5-methyl-2-
furyl, 3-pyridyl] with methyl aryl(heteryl) ketones(97) [R2 = Ph, 4-FC6H4, 4-ClC6H4, 4-
BrCeH4, 4-EtC6H4, 4-MeOC6H4]. The compound 95 on reaction with phenylhydrazine 
yielded l-phenyl-3-aryl (heteryi)-5-(4-pyrazolyl)-2-pyrazolines (98) [R1 = Ph, R2 = Ph, 4-
FC6H4, 4-ClC6H4. 4-BrC5H4, 4-EtC6H4, 4-MeOC6H4]. 
(95) (96) (97) (98) 
Kamernitsky et a/.63 synthesized 3/?-acetoxy-l'-[2' -oxo-2' -(2-pyridinylamino)] 
ethantione-3'-methylandrost-5-eno [16, \l-d\ pyrazoline (100) by refluxing a solution of 
dehydropregnenolone acetate (99) and thio-oxamine acid thiohydrazide in anhydrous 
pyridine for 3 h in the presence of catalytic amount of glacial acetic acid. The compound 
99 with 20% solution of NaOH in DMF was further stirred to give 3/?-hydroxy-3'-
methylandrost-5-eno [16, \l-d\ pyrazoline (101). 
(101) 
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Pimenov et al. were carried out the reaction of ketones (102) [n = 0, 1, 0, R = H, H. -
NO2] with 99% hydrazine under acidic conditions (acetic acid, sulphuric acid) which 
gave cyclic products 5-(l-adamantyl)-3-phenylpyrazoline (103) [same as above]. 
(102) (103) 
Condensation of 3/?-hydroxy-16-[(4-chlorophenyl) methyl-ene] androst-5-en-17-one 
(104) with hydrazine hydrate in acetic acid afforded l'-acetyl-l'-H-5'- (4-
chlorophenyl)androst-5-ene[17, 16-c]-pyrazolines-3/?-ol (105), while condensation of 104 
with semicarbazide afforded r-carbamoyl-l'-H-(2'-H)-5'- (4-chlorophenyl)androst-5-
ene[17, 16-c]-pyrazolines-3/?-ol (106). T-H-5'- (4-chlorophenyl) androst-5-ene [17, 16-
c]-pyrazolines-3/?-ol (107)65 was also prepared by refluxing the compound 104 and 
hydrazine hydrate in dioxane for 5 h. 
(104) (106) 
T 
N NH 
(107) 
59 
Ahmet Ozdemir et al b synthesized l-(4-aryl-2-thiazolyl)-3-(2-thienyl)-5-aryl-2-
pyrazoline derivatives (110) [Rl = H, CH3, OCH3, CI, N02 , Ar = ] by reacting 
substituted 3-(2-thienyl)-5-aryl-l-thiocarbamoyl-2-pyrazolines (109) [Ar same as above] 
with phenacyl bromides in ethanol. On the other hand the compound 109 was prepared by 
the reaction of l-(2-thienyl)-3-aryl-2-propen-l-ones (108) [Ar same as above] with 
thiosemicarbazide. Their antimicrobial activities of compound 110 against E. coli (NRRL 
B-3704), Staphylococcus aureus (NRLL B-767), Salmonella typhimurium (NRRL B-
4420), Bacillus cereus (NRRL B-3711), Streptococcus faecalis (NRRL B-14617). 
Aeromonas hydrophila (Ankara Uni. Fac. of Veterinary), Candida albicans and Candida 
glabrata (isolates obtained from Osmangazi Uni. Fac. of Medicine) were investigated. A 
significant level of activity was observed. 
O 
W/ W /x - / \ / \ 
-Ar 
:> \\ / 5 W / 
A r "' "
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x
' 
S^ ~NH2 
(109) 
(110) 
(108) 
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(Discussion 
Pyrazoline derivatives are important electron rich nitrogen heterocycles which play an 
important role in the diverse biological activities. These nitrogen heterocycles widely 
occur in nature in the form of alkaloids, vitamins, pigments and as constituents of plant 
and animal cells. Substituted pyrazolines have significant importance due to their wide 
spread pharmacological properties such as anti-carcinogenic, anti-diabetic, anti-
inflammatory, DP-IV inhibitors, anti-tumour and antiparkinsonian67"76. Some 
pyrazolines also showed anti-fungal activity77, which were assayed against 
Cephalosporium sacchan, Helminthosporium oryzae and Acheya orion and were found 
extensively active. In recent years, heterocyclic nitrogen derivatives showed general 
ionophoric potency for divalent cations78, and are used as novel thiocyanate-selective 
membrane sensors79. The above pharmaceutical interest and the continuation of our 
previous work80"83, encouraged us to synthesize some substituted steroidal pyrazolines 
The substrates selected for initial studies include cholest-5-en-7-one (111) , 3/?-
acetoxycholest-5-en-7-one (112)85 and 3/?-chlorocholest-5-en-7-one (113)86. The products 
obtained have been characterized on the basis of their elemental analysis and spectral (IR, 
'H-NMR, 13C-NMR, MS) studies. 
_X 
(111) H 
(112) AcO 
(113) CI 
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Reaction of cholest-5-en-7-one (111) with thiosemicarbazide and sodium ethoxide. 
A solution of cholest-5-en-7-one (111) and thiosemicarbazide in sodium ethoxide 
was refluxed for 6 h. After completion of reaction, the reaction mixture was concentrated 
under reduced pressure and acidified with 10 % HC1. It was cooled and then poured into 
cold water. The obtained solid, was extracted with diethyl ether and ethereal layer was 
washed with water, NaHCCh solution (5%), again with water, dried and recrystallized 
from dry methanol to give compound 114, m.p. 125 °C. 
^8^17 ^8^17 
f TSC/NaOC^Hs 
Reflux S) 
(111) 
Characterization of the compound, m.p. 125 °C as 2'-thiocarbamoyl-5«-cholestano 
[5,7-cd] pyrazoline(114): 
The elemental analysis of the compound corresponded to the molecular formula 
C28H47N3S. The IR data were very informative and provided evidence for the formation 
of the expected structure. The compound showed intense band in the region of 1281.5 
cm"1 due to (C=S) stretching of the thiocarbamoyl group and another band at 3428.4 cm" 
which could be assigned to NH group. In addition, other important absorption bands at 
1168.9 cm"1 and 1599.5 cm"1 were attributed to (C-N) and (C=N) respectively, which also 
confirmed the presence of expected pyrazoline moiety ' in the product molecule. 
Further, evidence for the formation of structure 114 was well supported by its *H NMR 
and 13C NMR. It's *H NMR spectrum exhibited a two-proton singlet at 6 8.7 for NH2 
(exchangeable with D20). Other important peaks for angular and side chain methyl 
protons were observed at S 1.13, 0.95, 0.87, and 0.70. 13C NMR spectrum of the 
62 
compound also supported the proposed structure and displayed characteristic signals at 8 
C2' (178.48), C3 (25.23), C5 (63.8), C6 (63.94), C7 (153.82). Remaining carbon atoms 
are seen in accordance to the cholestane series. The mass spectrum was also in great 
agreement with their molecular formula which exhibited a very strong molecular ion peak 
at m/z 457. 
On account of the above descriptive discussion, the compound can be suitably 
characterized as 2'-thiocarbamoyl-5a-cholestano [5, 7-cd] pyrazoline (114). 
Reaction of 3/?-acetoxychoIest-5-en-7-one (112) with thiosemicarbazide and sodium 
ethoxide. 
A solution of 3/?-acetoxycholest-5-en-7-one (112) and thiosemicarbazide in 
sodium ethoxide was refluxed for 10 h. After usual work up as before and 
recrystallization from dry methanol a solid compound 115 was obtained, m.p. 115 °C. 
CgH17 CgHr 
AcO 
TSC/NaOC2H5 
Reflux 
AcO 
NH2 
(112) (115) 
Characterization of the compound, m.p. 115 °C as 2'-thiocarbamoyl-3/?-acetoxy-5a-
cholestano [5,7-cd] pyrazoline (115): 
The elemental analysis of the compound corresponded to the molecular formula 
C30H49N3O2S. The IR data were very informative and provided evidence for the 
formation of the expected structure. The compound showed intense band in the region of 
1299 and cm"1 due to (C=S) stretching of the thiocarbamoyl group and another band at 
3450.1 crrf'which could be assigned to NH group. The IR spectrum of the compound 
exhibited strong absorption bands at 1735 and 1299 cm"1 indicating the presence of 
63 
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acetate group. In addition, other important absorption bands at 1168.4 cm"1 and 1632.4 
cm"1 were attributed to (C-N) and (C=N) respectively, which also confirmed the presence 
of expected pyrazoline moiety 80'66 in the molecule. Further, evidence for the formation of 
structure 115 was well supported by its ]H NMR and 13C NMR. It's ]H NMR spectrum 
exhibited a two-proton singlet at S 8.6 for NH2 (exchangeable with D20). A multiplet was 
observed at S 4.6 (W1/2 = 15Hz) which could be attributed to C3 (ecH) axial proton and the 
acetate protons were appeared at 8 2.02 as sharp singlet. Other important peaks for 
angular and side chain methyl protons were observed at 8 1.17, 0.93, 0.85 and 0.67. 
13C NMR spectrum of the compound also supported the proposed structure and displayed 
characteristic signals at 6 C2' (179.50), C3 (71.41), C5 (62.8), C6 (63.65), C7 (153.21). 
Remaining carbon atoms are seen in accordance to the cholestane series. The mass 
spectrum was also in great agreement with their molecular formula which exhibited a 
very strong molecular ion peak at m/z 515. 
On the basis of above studies and its analogy with earlier compound 114 this can 
be best characterized as 2'-thiocarbamoyl-3/?-acetoxy-5a-cholestano [5,7-cd] pyrazoline 
(115). 
Reaction of 3/?-chlorocholest-5-en-7-one (113) with thiosemicarbazide and sodium 
ethoxide. 
A solution of 3/?-chlorocholest-5-en-7-one (113) and thiosemicarbazide in sodium 
ethoxide was refluxed for 8 h. After usual work up of the reaction mixture, the crude 
product was recrystallized from dry methanol to give compound 116, m.p. 138 °C. 
TSC/NaOC7H^ 
Reflux 
(113) 
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Characterization of the compound, m.p. 138 °C as 2'-thiocarbamoyl-3/?-chloro-5a-
cholestano [5,7-cd] pyrazoline (116): 
The elemental analysis of the compound corresponded to the molecular formulae 
C28H46N3SCI (Beilstein positive). The IR data were very informative and provided 
evidence for the formation of the expected structure. The compound showed intense band 
in the region of 1286.4 cm"1 due to (C=S) stretching of the thiocarbamoyl group and 
another band at 3426.5 ctrf'which could be assigned to NH stretching. In addition, other 
important absorption bands at 1129.4, 1589 and 776 cm"1 were attributed to (C-N), (C=N) 
and (C-Cl) respectively, which also confirmed the presence of expected pyrazoline 
moiety 80'66 in the molecule. Further, evidence for the formation of the structure 116 was 
well supported by its :H NMR and 13C NMR. It's 'H NMR spectrum exhibited a two-
proton singlet at S 8.8 for NH2 (exchangeable with D2O). A multiplet was observed at 6 
3.9 (W1/2 =17 Hz) which could be attributed to C3 (aH) axial proton. Other important 
peaks for angular and side chain methyl protons were observed at S 1.10, 0.74, 0.95 and 
0.87. 13C NMR spectrum of the compound also supported the proposed structure and 
displayed characteristic signals at 8 C2' (176.61), C3 (59.6), C5 (63.08), C6 (63.70), C7 
(152.81). Remaining carbon atoms are seen in accordance to the cholestane series. The 
mass spectrum was also in great agreement with their molecular formula which exhibited 
very strong molecular ion peak at m/z 491/493. 
On the basis of the above descriptive discussion, the compound can be suitably 
characterized as 2'-thiocarbamoyl-3/?-chIoro-5oc-cholestano [5, 7-cd] pyrazoline (116). 
Formation of the steroidal pyrazolines 114-116 is rationalized on the basis of the 
proposed mechanism (Schemel) 
65 
NH2-NH-C-NH2 
NaOC2H5 ~* 
CgHn 
(114,115,116) 
X = H, OAc, CI 
Scheme-1 
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T^perimentaC 
Melting points were determined on a Kofler apparatus and are uncorrected. The IR 
spectra were recorded on KBr pellets with Pye Unicam SP3-100 spectrophotometer and 
its values are given in cm"1. 'H NMR spectra were measured in CDCI3 on a Bruker DRX-
300 spectrometer at 300 MHz and 13C NMR spectra at 100 MHz, with TMS as internal 
standard and its values are given in ppm (S). Mass spectra were recorded on a JEOL SX 
102/DA-6000 mass spectrometer using Argon/Xenon as the FAB gas. Thin layer 
chromatography (TLC) plates were coated with silica gel G and exposed to iodine 
vapours to check the homogeneity as well as the progress of reaction. Petroleum ether 
refers to a fraction of b.p. 60-80 °C. Sodium sulphate (anhydrous) was used as a drying 
agent. 
Cholest-5-ene: 
3y3-Chlorocholest-5-ene (10 g) was dissolved in warm amyl alcohol (230 mL) and 
sodium metal (20 g) was added in small portions to the solution with continuous stirring 
over a period of 8 h. The reaction mixture was warmed occasionally. When all sodium 
metal was dissolved, the reaction mixture was poured into water, acidified with dilute 
hydrochloric acid and allowed to stand overnight. A white crystalline solid thus obtained 
was filtered under suction and washed thoroughly with water and air dried. 
Recrystallization of the crude material from acetone gave cholest-5-ene in cubes (8.3 g), 
m.p. 88-89 °C (reported m.p. 89 -91 °C).84 
Cholest-5- en-7-one (111): 
A solution of butyl chromate [t-butyl alcohol (60 mL), Cr03 (20 g), acetic acid 
(84 mL) and acetic anhydride (10 mL)] 87 was added at 0 °C to a solution of cholest-5-
ene (8 g) in CC14 (150 mL), acetic acid (30 mL) and acetic anhydride (10 ml). The 
contents were refluxed for 3 h and then diluted with water. The organic layer was washed 
with sodium bicarbonate solution (5%) and water and then dried over anhydrous sodium 
sulphate. Evaporation of the solvents under reduced pressure provided cholest-5-en-7-one 
(111) which was crystallized from methanol (3.1 g), m. p. 128 °C (reported, m. p. 125-
129 °C).84 
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Reaction of cholest-5-en-7-one (111) with thiosemicarbazide and sodium ethoxide: 
2'-thiocarbamoyl-5a-cholestano[5,7-cd]pyrazoline (114): 
A solution of cholest-5-en-7-one (111) (1.9 g) and thiosemicarbazide (600 mg) in 
sodium ethoxide [sodium metal (230 mg) in 13 mL absolute ethanol] was refluxed for 6 h 
under anhydrous conditions. The progress of reaction was monitored by thin layer 
chromatography. After completion of reaction, the reaction mixture was concentrated 
under reduced pressure and acidified with 10 % HC1. It was cooled and then poured into 
cold water. The obtained solid was extracted with ether and ethereal layer was washed 
with water, sodium bicarbonate solution (5%), again with water and then dried over 
anhydrous sodium sulphate. The solvent was evaporated and the product was 
recrystallized from dry methanol to give compound 2'-thiocarbamoyl-5a-cholestano [5, 
7-cd] pyrazoline (114), m.p. 125 °C, yield 70%. 
Analysis found: C, 73.54; H, 10.31; N, 9.12. 
C28H47N3S requires: C, 73.52; H, 10.28; N, 9.19 %. 
IR(KBr): vmax 3428.4 (NH2), 1599 (ON), 1281.5 (C=S), 1168.9 cm"1 (C-N). 
'H-NMR (CDCI3): 6 8.7s (2H, NH2> exchangeable with D20), 1.13s (3H C,o-CH3), 0.70s 
(3H, C,3- CH3), 0.95d (3H, C20-CH3), 0.87d (6H, C25-2xCH3). 
13C-NMR (CDCI3): 6 C2' (178.48), C3 (25.23), C5 (63.8), C6 (63.94), C7 (153.82), C8 
(32.83), C9 (51.68), C10 (35.96), C18 (11.86), C19 (17.33), C25 (28.08), C26 (21.78), 
C27 (22.64) 
MS: w/z457(M+) 
3/?-AcetoxychoIest-5-ene: 
A mixture of cholesterol (100 g), pyridine (150 mL, freshly distilled over KOH) 
and freshly distilled acetic anhydride (100 mL) was heated on water bath for 2 h. The 
reaction mixture was poured into ice-cold water and the solid thus obtained was filtered 
under suction, washed thoroughly with water until free from pyridine and then air-dried. 
Recrystallization of the crude product from acetone gave 3/?-acetoxycholest-5-ene (95 g), 
m.p. 114 °C (reported, m.p. 115-116 °C).88 
68 
3/?-Acetoxycholest-5-en-7-one (112): 
A solution of butyl chromate [t-butyl alcohol (60 rnL), Cr03 (20 g), acetic acid 
(85 mL) and acetic anhydride (10 mL)]87 was added at 0 °C to a solution of 3/?-
acetoxycholest-5-ene (8 g) in CC14 (150 mL), acetic acid (30 mL) and acetic anhydride 
(10 mL). The contents were refluxed for 3 h and then diluted with water. The organic 
layer was washed with sodium bicarbonate solution (5%) and water and then dried over 
anhydrous sodium sulphate. Evaporation of the solvents under reduced pressure furnished 
3/?-acetoxycholest-5-en-7-one (112) which was crystallized from methanol (3.2 g), m. p. 
161-163 °C (reported, m. p. 164 °C).85 
Reaction of 3/?-acetoxycholest-5-en-7-one (112) with thiosemicarbazide and sodium 
ethoxide: 2'-thiocarbamoyl-3p-acetoxy-5a-cholestano[5,7-cd]pyrazoline (115): 
A solution of 3/?-acetoxycholest-5-en-7-one (2) (2.2 g) and thiosemicarbazide 
(600 mg) in sodium ethoxide [sodium metal (230 mg) in 13 ml absolute ethanol] was 
refluxed for 10 h. The progress of reaction was monitored by thin layer chromatography. 
After completion of reaction, the reaction mixture was concentrated under reduced 
pressure and acidified with 10 % HCl. It was cooled and then poured into cold water. The 
obtained solid, was extracted with ether and ethereal layer was washed with water, 
sodium bicarbonate solution (5%), again with water and dried over anhydrous sodium 
sulphate. The solvent was evaporated and the product was recrystallized from dry 
methanol to give 2'-thiocarbamoyl-3/?-acetoxy-5a-cholestano [5, 7-cd] pyrazoline (115), 
m.p. 115°C, yield 85%. 
Analysis found: C, 69.95; H, 9.55; N, 8.17. 
C30H49N3O2S require: C, 69.90; H, 9.51; N, 8.15. 
IR (KBr): vmax 3450.1 (NH2), 1735 and 1299 (CH3COO), 1632.4 (C=N), 1299 (C=S), 
1168.4 cm"1 (C-N). 
'H-NMR (CDCI3): S 8.6s (2H, NH2, exchangeable with D20), 4.6m (1H, C3-«H, W1/2=15 
Hz), 2.02s (3H, CH3COO), 1.17s (3H, CI0-CH3), 0.67s (3H, C13-CH3) 0.93d (3H, C20-
CH3), 0.85d (6H, C25-2xCH3). 
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13C-NMR (CDCb): S CT (179.50), CH3COO (170.61), C3 (71.41), C5 (62.8), C6 
(63.65), C7 (153.21), C8 (35.72), C9 (51.04), CIO (35.08), C18 (11.83), C19 (17.10), 
C25 (28.07), C26 (22.63), C27 (22.63). 
MS:w/z515(M+) 
3/?-Chlorocholest-5-ene: 
Freshly purified thionyl chloride (75 mL) was added gradually to cholesterol (100 
g) at room temperature. A vigorous reaction ensued with evolution of gaseous products. 
When the reaction slackened, the reaction mixture was gently heated at temperature of 50 
- 60 °C on a water bath for 1 h and then poured into ice cold water with constant stirring. 
The yellow solid thus obtained was filtered under suction, washed several times with cold 
water and air-dried. Recrystallization from acetone gave 3/?-chlorocholest-5-ene (92 g), 
m.p. 95-96 °C (reported, m.p.96-97 °C).89 
3/?-Chlorocholest-5-en-7-one (113): 
A solution of butyl chromate [t-butyl alcohol (60 mL), CrC«3 (20 g), acetic acid 
(35 mL) and acetic anhydride (10 mL)] 7 was added at 0 °C to a solution of 3/?-
chlorocholest -5-ene (8 g) in CCl4(150 mL), acetic acid (30 mL) and acetic anhydride (10 
mL). The contents were refluxed for 3 h and then diluted with water. The organic layer 
was washed with sodium bicarbonate solution (5%) and water and then dried over 
anhydrous sodium sulphate. Evaporation of the solvents under reduced pressure furnished 
3/?-chlorocholest-5-en-7-one (113) which was crystallized from methanol (3.4 g), m. p. 
144 °C (reported, m. p. 144 -145 °C ).86 
Reaction of 3/?-chlorocholest-5-en-7-one (113) with thiosemicarbazide and sodium 
ethoxide: 2'-thiocarbamoyl-3p-chloro-5a-cholestano[5,7-cd]pyrazoline (116): 
A solution of 3/?-chlorocholest-5-en-7-one (113) (2.0 g) and thiosemicarbazide 
(600 mg) in sodium ethoxide [sodium metal (230 mg) in 13 ml absolute ethanol] was 
refluxed for 8 h. The progress of reaction was monitored by thin layer chromatography. 
After completion of reaction, the reaction mixture was concentrated under reduced 
pressure and acidified with 10 % HC1. It was cooled and then poured into cold water. The 
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obtained solid was extracted with ether and ethereal layer was washed with water, sodium 
bicarbonate solution (5%), again with water and dried over anhydrous sodium sulphate. 
The solvent was evaporated and the product was recrystallized from dry methanol to give 
2'-thiocarbamoyl-3/?-chloro-5a-cholestano [5, 7-cd] pyrazoline (116), m.p. 138°C, yield 
65 %. 
Beilstein positive 
Analysis found: C, 68.45; H, 9.32; N, 8.58. 
C28H46M3CIS requires-. C, 68.43; H, 9.36; N, 8.55. 
IR (KBr): vmax 3426.5 (NH2), 1589 (C=N), 1286.4 (C=S), 1129.4 (C-N), 776 cm"1 (C-Cl). 
'H-NMR (CDCI3): S 8.8s (2H, NH2, exchangeable with D20), 3.9m (1H, C3-aH, W,/2=17 
Hz), 1.10s (3H, C10-CH3), 0.74s (3H, Q3-CH3), 0.95d (3H, C20-CH3), 0.87d (6H, C25-
2xCH3). 
13C-NMR (CDCI3): d C2' (176.61), C3 (59.6), C5 (63.08), C6 (63.70), C7 (152.81), C8 
(32.58), C9 (51.51), CIO (35.79), C18 (11.82), C19 (16.98), C25 (29.81), C26 (22.65), 
C27 (21.98) 
MS: m/z 491/493 (M^)-
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CHAPTER-3 
SteroidalOxazofes 
TfteoreticaC 
For many years the development of oxazole chemistry followed a somewhat restricted 
path. This was due not so much to a paucity of synthetic method as to the circumstances 
that all the methods available gave their best results in the synthesis of aryl or polyalkyl 
oxazoles. As a result the preparation of such substances came to the principal features of 
oxazole chemistry. Other aspects such as introduction, modification and removal of 
substituents were neglected largely because of the difficulty of preparing compounds 
suitable for study. No substance containing the oxazole system has been found to occur 
naturally and this may be the reason why there have never been many workers in the 
oxazoles field. 
The joint Anglo-American effort to synthesize penicillin, however led to 
considerable progress. Although this fascinating molecule contains no oxazole ring, many 
oxazole derivatives were made in the course of the work, some of them being possible 
intermediate for the synthesis of antibiotic. The way has thereby been opened for a study 
of precisely those aspects of the oxazole chemistry, which received least attention in the 
past. 
Of the various methods developed the synthesis of oxazoles from a-haloketones, 
a-azidoketones and diazoketones constitute few of the important routes. 
2-Aminooxazole (1) was synthesized by condensing a -haloketones with urea. '" 
Rv R 
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4, 5, disubstituted oxazoles (2) can also be obtained by the reaction of a-bromoketone 
and ammonium formate in formic acid.3 
R—CH-C-R 1 + HCOONR, 
I II 
Br O 
R R 
(2) 
Mostly aryl substituted oxazoles have been synthesized by this method. Few reports are 
also available for the synthesis of 4, 5 dipropyl-oxazoles. 
Reaction of substituted urea with a-bromocycloalkanone afforded 4, 5-methylene-
2-amino oxazoles (3).4 
O 
Br 
,(CH2)n 
RR'N— C-NH2 
II 
o 
NRR 
(3) 
Nitrilium salt (4) on cyciization afforded 2, 4-disubstituted-5-phenyloxazole (5). 
Ph R 
R 
O 
II 
Ph—C-CH 
rf=CR! C> / N 
R1 
(4) (5) 
Chung-gi-shah et al6 synthesized the /-butyl-5-alkyl-2-methyl oxazole-4-carboxylate (7) 
by the treatment of /-butyl-2-acetylamino-3-bromo-2-alkanoate (6) with triethylamine 
followed by dehydrobromination, but no reaction occurred with primary amines. 
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R 
R—C=C—C02But 
I I 
Br NHCOCH3 
(6) 
EhN 
C02But 
CX ,N 
(7) 
/?-Haloacylamino- a, /^-unsaturated acid (8) was converted to oxazole-4-carboxylic 
(9) with sodium acetate-acetic acid when heated with silver fluoride as catalyst. 
R C02H 
R—C=C—C02H NaOAc-ACOH^ / ^ ^ 
AgF (X .N 
X NHCOR 
(8) 
R 
(9) 
Cyclization reactions of a-hydroxy enamides (10 and 11) have been utilized in 
syntheses of oxazolopyranones (12) and oxazolocoumarins. (13). -10 
OH 
O 
NHCOR 
O 
(10) 
Ac20 
0 
R 
N 
O' O 
(12) 
CL ^O 
NHCOR 
(11) 
Ac20 
O^ / O 
(13) 
R= alkyl, aryl 
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N-Acyl-l-cyano-2, 2-dichlorovinylamine (14) on treatment with secondary amine under 
acid catalysis afforded 4- cyano-5-(N, N-disubstituted)-amino-oxazoles (15)." 
CL 
CV 
C = C - N H - C - R 
7
 I II 
C N O 
(14) 
R 
R 2^NH 
H© 
Toulenesulphonic acid salt of amino malononitrile (16) on reaction with acetic anhydride 
afforded 17.12 
CN NH2 
-CN (CH3C0)20> / \ 
CN * N ^ O 
SO3-NH-CH; 
(16) (17) 
1, 3, dipolar addition of carbonyl carbenes to the nitriles or unsaturated compounds was 
found in valuables for the synthesis of 5-membered ring heterocycles and has been the 
subject of extensive reviews. 3"15 Diazoketones (18) on treatment with benzonitriles 
yielded oxazoles (19).16 
Ph 
= N 2 
(18) 
PhCN 
(19) 
Photochemical transformations of trifluro acetyldiazo-acetic ester (20) with acetonitrile 
provided ethyl-2-methyl-5-trifluromethyIoxzoles-4-carboxylate (21). Photolysis of which 
afforded (22).I7J8 
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Et02C, 
F 3 C - C - C - C 0 2 E t ^ M 2 ^ 
O N2 
(20) 
CF3 
N, , 0 
(21) 
Et02C cc>2Et 
N. 
o-
,N 
CF3 CF3 
(22) 
~0 
Photochemically induced reaction of methyl azidoformate (23) with 2-butyne gave 
oxazole (25).19 The reaction involves 1, 3 dipolar cycloadition of acylnitrene (24). 
CH 3 N CH3 
.0 
MeC02N3 
(23) 
. . _ _. H 3 CC=CCH 3 / 
MeO—Cx — V N 
• 0~ 
MeO— c ' 
N 
O 
OCH3 
(25) 
(24) 
a-Azido ketone (26) on treatment with acyl halide in the presence of triphenyl phosphine 
afforded oxazoles (27).2< Same oxazoles can also be obtained by similar treatment with a-
azido ester.21 
R'—CH-C—IO 
! II 
Ni O 
(26) 
-f- R3—COX Ph.P 
Bz 
Thermolysis of trans-{3-az\do vinylphenyl ketone (28) yielded 5-phenyloxazoles (30). 
The mechanism for the formation of oxazoles involves 3-benzoyl-l-azirine (29) as 
intermediate 22 
81 
(28) 
O 
Ph H C=C ' 
/ \ 
H N: 
V 
O 
(29) 
.Ph 
N v ,0 
(30) 
23 A more facile method for the synthesis of oxazoles from ketoximes was also reported. 
Bhatt and Reddy24 prepared oxazoles (32) from ketoximes (31) by treatment with 
acetic anhydride- pyridine and acetyl chloride followed by cyclocondensation with HCl. 
NOH 
(31) 
Rl R' 
Ac' 
.N O 
Ac 
O ^ 
R< R2 
N O 
(32) 
Trans-2, 3, 3a. 4, 5, 9b-hexahydro-7-hydroxy-3a-methyl-lH-benz[e] inden-3-one (33) 
transformed into isomeric benzoxaoles (34). (35) and corresponding formats (36) and 
(37) through following sequence of reaction.° 
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o 
H 
HO' 
NO2 
l.NaBR, 
2.NH2.NH2 
3. Raney Ni 
t O 
H 
HO' 
NH2 
(34) 
CH(OEt)3 
O 
H 
O 
=N 
(36) 
(33) 
NH2. 
HO' 
N-
1 .NaBH4 
2.NH2.NH2 
3.Raney Ni 
O 
H 
(35) 
CH(OEt)3 
O 
H 
(37) 
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17y3-Acetoxy-5a-androstan-3-one (38) on treatment with Lead tetraacetate and BF3-Et20 
afforded 39 which was converted to oxazole (40) by Davidson reaction26 using 
ammonium acetate and acetic acid. 
OAc OAc 
NH4OAc/ 
AcOH 
(40) 
2«-Acetoxy or 2a-bromo-3-ketones of androstane and cholestane series 42-49 were 
converted into respective 2'-methyl steroidal [3, 2-d] oxazoles (50-57) by reaction with 
ammonium acetate. 
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R'o2 
(41) 
R R' R^  
42 
43 
44 
45 
46 
47 
48 
49 
Aco 
Aco 
Aco 
Aco 
Br 
Br 
Br 
Br 
OH 
OAc 
OH 
C8H17 
OH 
OAc 
OH 
CgHn 
H 
H 
CH3 
H 
H 
H 
CH3 
H 
R R1 R2 
50 Aco OH H 
51 Aco OAc H 
52 Aco OH CH3 
53 Aco C8H17 H 
54 Br OH H 
55 Br OAc H 
56 Br OH CH3 
57 Br Q H n H 
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Reductive acylation of (58-60) gave 2a-acetamido-3-ketones (61-63) which were 
cyclized by sulphonic acid to give 2-methyl steroidal [2, 3 d]-oxazoles (64-66).27 
HON AcHN 
R' Rz 
58 OH H 
59 OAc H 
60 C8H17 H 
R1 R^ 
61 OH H 
62 OAc H 
63 C8H17 H 
R1 R2 
64 OH H 
65 OAc H 
66 C8H17 H 
a-Azido ketones (67) and (68) prepared from 2a-bromochoIestan-3-one and 7a-
bromocholestan-6-one respectively, underwent cycloaddition reaction with acyl halide in 
the presence of PhjP to give oxazolo-steroids 69 and 70.28 
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CgHw CgHi? 
RCOX 
(67) 
CgHn 
AcO 
(68) 
Ph.P 
RCOX 
R X 
CH3 Br 
Ph CI 
PhCH2 CI 
AcO" 
(69) 
CgH,7 
IS 
h \ // 
0 ^ 
(70) R 
Treatment of acetyl steroid (71) with NH2OH gave the oxime (72) which on treatment 
with sulphonyl chloride or p-toluene sulphonyl chloride in pyridine afforded 2'-methyl 
29,30 benzoxazole (73) while in KOH furnished 3'-methyl benzoxazole (74).zy'JU A somewhat 
similar method was used for the preparation of benzoxazole and benzisoxazole. 31 
87 
OAc OAc 
(71) (72) 
p-TsCl/Py 
(74) (75) 
2'-Organylamino-l. 7-oxoestra-l (10), 4-dieno [2, 3-d] oxazoles (77) were prepared 
conveniently and in high yield by treating 2-aminoestrone (76) with aryl isothiocyanates 
in the presence of DCC.3~ 
O O 
ArNCS 
(76) (77) 
Shafiullah and Ansari33 synthesized steroidal oxazoles (80-81) by the reaction of steroidal 
oximes (78-79) in dry pyridine-acetic anhydride with acetyl chloride followed by 
cyclization with dry HC1 (gas) 
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C8H,7 CgHI7 
NOH 
X 
(78) CI 
(79) OAc 
(i)Ac2Q/Py/AcCl 
(ii) Hcl (gas) 
X 
(80) CI 
(81) OAc 
2-Aminoethanol, 2-amino-l-propanoI and 3-amino-l-propanol reacted as 
monoalkylamines with 2-alkoxy-l-aryl-l, 2-dihydro 3, 1, 225 benzothiazaphosphinine-2, 
4-dithiones (82) and afforded 2-arylamino-N-(hydroxyalkyl)-thiobenzamides (83-85). 
When 2-aminoethanol was used, the thiobenzamide 83 was sometimes accompanied by a 
2-(2-arylaminophenyl)-4, 5-dihydrooxazole 86, 34 
Ar 
^OR 
(82) 
NH2—CH2Y 
NHAr 
Y 
83 CH2OH 
84 CHOH-CH3 
85 CH2-CH2-OH 
X- H, CI 
NHAr 
(86) 
'35 Shoji Eguchi et al. synthesized oxazoles by an intramolecular aza-Wittig reaction. The 
a-azido ketones (87) were converted to (3- (acyloxy)vinyl azides (88) with the help of 
lithium diisopropylamide (LDA).These vinyl azides 88 when treated with triethyl 
phosphite afforded 2-methyl-5-phenyloxazoles (89). 
89 
LDA 
(87) 
P(OEt)3 
(89) 
Habib et al.36 reported an efficient method for the formation of 4-(benzylidene-4'-
benzenesulphonate)-2-phenyl-2-oxazolin-5-one (91) by the treatment of 
benzenesulphonate of p-hydroxybenzaldehyde (90) with hippuric acid in the presence of 
acetic anhydride and sodium acetate. 
-so3- CHO 
,0 
CH=- C—C 
/ \ 
Ny° 
CeH, 
(90) (91) 
Paul Froyen37 synthesized /?-keto carbodiimides (93) by reacting 2-azido ketones (92) 
with triphenylphosphine in the presence of isocyanates or isothiocyanates. The /?-keto 
carbodiimides were readily transformed into 2-amino-l, 3-oxazoles (94). 
PPh, 
ArN = 
ArNCO/ArNCS O 
(92) (93) 
2 Oxalic acid 
Dioxane 
ArHN 
Didier Villemin38 performed the cyclo-condensation of 2-formyl thiophene (95) with 2, 3 
butadienone to give 96, which on further treatment with zinc and glacial acetic acid 
afforded corresponding oxazoles (97). 
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(95) 
CH3 
• HC1 -Z& *-
CH3 CH3COOH -CH* 
(96) (97) 
Moody et al.i9 prepared oxazoles (99) from diazocarbonyl compounds (98) with nitriles 
in the presence of rhodium as a catalyst. 
,2 N „ R 
R'CN 
catRh 2+ 
or "RJ 
(98) 
N . Rz 
(99) 
Moody et al40 prepared amides (100) from the corresponding TV-protected amino acids by 
anhydride formation with ethyl chloroformate followed by reaction with aqueous 
ammonia. The a-diazo /?-keto esters (101) were prepared by diazo transfer reaction on the 
corresponding /i-keto esters. The rhodium (II) acetate catalysed NH insertion reaction 
proceeded readily in boiling chloroform and gave the products 102. Cyclo-dehydration of 
the /?-carbonylamides (102) gave oxazoles 103 in good yield. 
R ! ^ N H 2 Y 
o 
(100) 
N,N Z RL NH Z 
^ ' Rh2(OAc)4 ^ J 
O 
O ^ R 2 
(101) 
Ph^P 
c r R7 
(102) 
Rl-
N Z 
O 
(103) 
•41 Li-Xin Dai reported the reaction of N-sulfonylimines (104) with isocyanoactamide 
(105) to give trisubstituted oxazoles (106). Moreover, the trisubstituted oxazoles can be 
easily converted into the corresponding polyamines, dipeptides and useful building 
blocks for the synthesis of the biologically active compounds. 
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2R1CH=NTs + CNCH2CONR2 
(104) (105) 
R2N 
NHTs 
Suzuki and Ueno42 synthesized 1, 2-oxazole (107) by 1, 3-dipolar cycloaddition reaction 
of nitrile oxide which is synthesized by reaction of oxime with phenylpropargylaldehyde. 
P h - C = C - C H O + Ar-CH=NOH- NaOCI 
CH2C12 
Claudio Saitz et a/43 transformed 2-phenyl-3H-naphtho[2,l-b][l,4]-oxazin-3-one (106), 
3-phenyl-2H-naphtho[l,2-b][l,4]oxazin-2-one (107), 3-phenyl-2H-naphtho[2,3-b][l,4]-
oxazin-2-one (108), and 3-phenyl-2H-benzo[b][l,4]oxazin-2-one (109) into 2-
phenylnaphtho[l,2-d]oxazole (110), 2-phenylnaphtho[2,l-d]oxazole (111), 2-phenyl 
naphtho[2,3-d]oxazole (112) and 2-phenylbenzo[d]oxazole (113) on heating with KOH in 
methanol. 
KOH 
(106-109) 
Ar 
(106) 1,2-benzo-
(107) 1,2-naphtho-
(108) 2, 1-naphtho-
(109) 2. 3-naphtho-
MeOH 
(110-113) 
Ar 
(110) 1,2-benzo-
(111) 1,2-naphtho-
(112) 2, 1-naphtho-
(113) 2, 3-naphtho-
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Usifoh and Okunrobo44 reported carbonylation of o-amino-N-(l,l-dimethylprop-2-ynyl)-
benzamide (114) with ethyl chloroformate to get 2-carbethoxyamino-N-(l,l-
dimethy]prop-2-ynyl)-benzamide (115) which under basic conditions cyclized to 2-(o-
carboethoxyaminophenyl)-4,4-dimethyl-5-methylene-4H-oxazole (116). 
0 CH3 
NH2 
(114) 
NHCOC2H5 
o 
(115) 
NHCOC2H5 
11 
0 
(116) 
Babaev and Nasonov45 reported that in a one-pot reaction piperidine readily transformed 
2-methylsulfanyl-ALphenacylpyridinium salts (119) into 2-[4-(l-piperidino)-l,3-
butadienyl][l,3]oxazoles (120) at room temperature. The starting materials 119 could be 
readily obtained either by introducing phenacyl groups into 2- methylsulfanylpyridine 
(117) or by methylation of jV-phenacylpyridine-2-thiones (118) with methyl iodide. 
,SMe 
R= 4-BrC6H4 
X= Br, I 
,46 Schiketanz et al. gave a method for the acylaminoacylation of aromatic hydrocarbons 
with 2-[4-benzenesulfonyl-(4-halophenyl)]-5-oxazolones (121) in the presence of 
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anhydrous aluminum chloride which lead to the formation of 2-aza-l, 4-diones (122). 
The compound 122 get cyclized under the action of phosphorus oxychloride to afford the 
corresponding 2-[4-(4-halobenzenesulphonyl)-phenyl]-5-aryloxazoles (123) 
cr ^o Aicij 
(121) 
CH2C1; POC13 
(123) 
Lee and Lee47 reported an efficient method for a-sulfonyloxylation of various carbonyl 
compounds with [hydroxyl (2, 4-dinitrobenzenesulfonyloxy) iodo] benzene (HDNIB) in 
acetonitrile at room temperature. The required HDNIB can be easily obtained from the 
reaction of iodobenzene diacetate and 2, 4-dinitrobenzenesulfonic acid in excellent yield. 
Ketones 124 with HDNIB in nitrites 125 were refluxed for 2 h and on subsequent 
addition of catalytic amount of 2, 6-lutidine (0.1 equiv.) with prolonged heating of 
additional 12 h afforded the corresponding oxazoles 126 in high yields. 
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R 
+ R 2 _ C N HDNIB „ Rz 
R1 "N 
(124) (125) (126) 
Chen et a/.48 prepared 2, 5-disubstituted oxazoles (137-141) conveniently by treatment of 
aromatic a-methyl ketones (127-131) and nitriles 131-136 with 
polyfstyrene(iodosodiacetate)] in one-pot process. 
0 I 
A r / CH3 
Ar 
(127) C6H5 
(128) 4-ClC6H4 
(129) 4-BrC6H4 
(130) 4-CH3C6H4 
(131) 4-CH3OC6H4 
+ RCN * \ _ 
CF3SO3H 
R 
(132) CH3 
(133) CH3 
(134) CH3 
(135) CH3 
(136) CH3 
f — I (OAc)2 
>-
, CH2C12 
(137) 
(138) 
(139) 
(140) 
(141) 
jr\ 
Nr^Q 
Ar 
C6H5 
4-ClC6H4 
4-BrC6H4 
4-CH3C6H4 
4-CH3OC6H4 
"R 
R 
CH3 
CH3 
CH3 
CH3 
CH3 
Evindar and Batey49 reported a method for the formation of benzoxazoles (143) via 
copper-catalyzed cyclization of or^o-haloanilides (142). The reaction involved an 
intramolecular C-0 cross-coupling of the or/Zzo-haloanilides and was believed to proceed 
via an oxidative insertion/reductive elimination pathway through a Cu (I)/Cu (III) 
manifold. The reaction is also applicable to the formation of benzothiazoles. 
Cul 
CS2CO3/DME 
(143) 
Z=0, S 
X= CI, Br, I 
Martinez-Alvarez et al™ performed the reaction of l-(methylthio) acetone (144) with 
different nitriles in the presence of triflic anhydride which led to the one-pot formation of 
50 
95 
2-substituted 5-methyl-4-methylthio-l, 3-oxazoles (145) in good yield. 1, 2- and 1, 4-
bisoxazolyl-substituted benzenes were also obtained when the reaction was carried out 
using aromatic dinitriles. 
Tf20 
MeS„ 
MeS. 
~Me 
Me 
RCN 
OTf 
^ // N " 
Me 
SMe 
(144) 
N- " 
(145) 
-Me 
Pinto et al.5] synthesized furan [4, 3-b] naphtho[l,2-d]oxazole (148) pyran [4, 3-b] 
naphtho[l,2-d]oxazole (149) by the reaction of naphthoquinone oximes (146-147) with 
diazomethane. 
R 
n 
(146) 1 
(147) 2 
(148) 1 
(149) 2 
Zwawiak et al52 synthesized 2,3-dihydro-7-nitroirnidazo[5,l-b]oxazoles (151) in one-pot 
reaction b> the treatment of 4.5-dinitroimidazole (150) with oxiranes (1, 2-
epoxypropane/1, 3-epoxybutane). The obtained compounds have been tested in vitro for 
anti-mycobacterial activity. 
N0 2 
(150) (151) 
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(Discussion 
Oxazole derivatives are important heterocycles with oxygen and nitrogen separated by 
one carbon atom. The oxazoles are important structural units, which are present in a wide 
variety of biologically active natural products as well as in useful synthetic intermediates. 
Most of these compounds showed significant biological activities such as anti-tumor, 
anti-leukemia, anti-viral, anti-fungal, anti-inflammatory, anti-bacterial, herpes simplex 
virus type-1 (HSV-1) inhibitors, and analgesic53"57. Oxazoles have been used both as a 
primary scaffold and as a component of the peptide fragment. A series of oxazole 
benzene sulfonamides have recently been introduced as fl-3 adrenergic receptor 
agonists.5 Another recent example explored dopamine receptor binding profiles of a 
series of phenyl oxazoles.59 Oxazoles are also common structural motifs in nature 
originating from post-translational modifications of serine and threonine residues in 
peptides.60 Oxazole derivatives also found their wide application as scintillating 
materials. Substituted oxazoles were recognized as intermediates for the synthesis of 
antibiotics61 and used as azadienes in Diel's-Alder reactions.62"65 The above 
pharmaceutical and synthetic interest prompted us to undertake the synthesis of steroidal 
oxazoles from easily accessible steroidal ketones such as 5<2-cholestan-6-one (152r, 3/3-
acetoxy-5<2'-cholestan-6-one (153)67 and 3/2-chloro-5<2-cholestan-6-one (154) . The 
products obtained have been characterized on the basis of their elemental analysis and 
spectral (1R, 'H-NMR, 13C-NMR, MS) data. 
X 
(152) H 
(153) AcO 
(154) CI 
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Reaction of 5or-choIestan-6-one (152) with urea and iodine. 
A solution of steroidal ketone 152, iodine and urea in absolute ethanol was 
refluxed for about 18 h. After completion of reaction the excess solvent was removed to 
three fourths of the original volume under reduced pressure. The reaction mixture was 
suspended in water (30 mL) and neutralized with saturated aqueous NaHCC^ solution 
and filtered by suction. The ethereal layer was further washed with water and dried over 
anhydrous sodium sulphate. Removal of solvent gave the crude product, which was 
recrystallized from methanol to give compound 155, m.p. 115 °C. 
Iodine/Urea 
EtOH, Reflux 
152 
Characterization of the compound, m.p. 115 °C as 2'-amino-5a-choIest-6-eno [6,5-d] 
oxazole (155): 
The compound 155 was correctly analysed for C28H46N2O. The examination of 
the IR spectrum of this compound suggested the formation of the expected structure. It 
showed the characteristic absorption bands at 3473 cm"1 for (N-H) group, at 1610 cm" 
for (C=C) stretching and another band at 1520 cm"1 for (C=N) stretching. Other important 
bands were exhibited at 1455 and 1064 cm"1 for (C-N) and (C-O) stretchings respectively. 
The 'H-NMR spectrum of the compound displayed a two-proton singlet at 5 5.8 for NH 
(exchangeable with D2O). A broad singlet for one proton at S 5.5 was assigned to C7-
olefinic proton. Angular and side-chain methyl protons appeared at S 1.13, 0.90, 0.80 and 
0.72. 13C NMR spectrum of the compound also supported the proposed structure and 
displayed characteristic signals at S C2' (163), C6 (146.4), C7 (135), C5 (76.2), C3 
(19.4). Remaining carbon atoms are seen in accordance to the cholestane series. The mass 
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spectrum was also in great agreement with their molecular formula which exhibited a 
very strong molecular ion peak at m/z 426. 
Thus, the compound 155, on the basis of its molecular composition and spectral 
evidences could best be characterized as 2'-amino-5a-cholest-6-eno [6, 5-d] oxazole 
(155). 
Reaction of 3/?-acetoxy-5<z-cholestan-6-one (153) with urea and iodine. 
A solution of steroidal ketone 153, iodine and urea in absolute ethanol was 
refluxed for about 22 h. After completion of reaction the excess solvent was removed to 
three fourths of the original volume under reduced pressure. After usual work up of the 
reaction mixture, the crude product was recrystallized from methanol to give compound 
156, m.p. 79 °C. 
AcO 
Iodine/Urea 
EtOH, Reflux 
AcO 
153 
Characterization of the compound, m.p. 79 °C as 3/?-acetoxy -2'-amino-5a-cholest-6-
eno [6,5-d] oxazole (156): 
The compound 156 was correctly analysed for C30H48N2O3. The examination of 
the IR spectrum of this compound suggested the formation of the expected product. The 
compound showed the characteristic absorption band at 3435 cm"1 for (N-H) group. 
Strong bands at 1735 and 1299 cm"1 were due to (OCOCH3), a band at 1620 cm"1 was 
assigned to (C=C) stretching and other bands at 1520, 1455 and 1045 cm"1 were 
attributed to (C=N), (C-N), and (C-O) stretchings respectively. The ' H-NMR spectrum of 
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the compound exhibited a two-proton singlet at 3 5.8 for NH (exchangeable with D20). A 
broad multiplet was observed at 3 4.7 (W\n = 15 Hz, axial) which could be assigned to 
C}-a proton and the acetate group protons were appeared at 3 2.01 as a sharp singlet. A 
broad singlet at 3 5.5 was assigned to C7-olefinic proton. Angular and side-chain methyl 
protons appeared at 3 1.12, 0.92, 0.85 and 0.71. 13C NMR spectrum of the compound also 
supported the proposed structure and displayed characteristic signals at 3 OCOCH3 
(170.1), C2' (163), C6 (146.2), C7 (122), C5 (70.2), C3 (68.9). Remaining carbon atoms 
are seen in accordance to the cholestane series. The mass spectrum was also in great 
agreement with their molecular formula which exhibited a very strong molecular ion peak 
at m/z 484. 
On the basis of above studies and its analogy with earlier compound 155 this 
could best be characterized as 3/?-acetoxy-2'-amino-5a-cholest-6-eno [6, 5-d] oxazole 
(156). 
Reaction of 3y5-chIoro-5ar-cholestan-6-one (154) with urea and iodine. 
A solution of steroidal ketone 154, iodine and urea in absolute ethanol was 
refluxed for about 20 h. After completion of reaction the excess solvent was removed to 
three fourths of the original volume under reduced pressure. After usual work up of the 
reaction mixture, the crude product was recrystallized from methanol to give compound 
157, m.p. 80 °C. 
O 
154 
100 
Iodine/Urea 
EtOH, Reflux 
Characterization of the compound, m.p. 80 °C as 3/?-chloro -2'-amino-5a-cholest-6-
eno [6,5-d] oxazole(157): 
The compound 157 was correctly analysed for C28H45N2OCI (Beilstein positive). 
The examination of the 1R spectrum of this compound suggested the formation of the 
expected structure. The compound in its IR spectrum showed the characteristic 
absorption bands at 3440 cm"1 for (N-H) group, at 1610 cm"1 for (C=C) stretching and at 
1510 cm"' (C=N) stretching. Other important bands at 1450, 1055 and 710 cm"1 were 
assigned to (C-N), (C-O) and (C-Cl) stretchings respectively. The 'H-NMR spectrum of 
the compound exhibited a two-proton singlet at S 5.9 for NH (exchangeable with D2O). A 
multiplet was observed at S 3.9 (W1/2 =17 Hz) which could be attributed to C3 (aH) axial 
proton. A broad singlet at 5 5.2 was assigned to C7-olefinic proton. Angular and side-
chain methyl protons appeared at S 1.11, 0.91, 0.82 and 0.71. 13C NMR spectrum of the 
compound also supported the proposed structure and displayed characteristic signals at S 
C2' (155), C6 (146.2), C7 (125), C5 (70.2), C3 (59.6). Remaining carbon atoms are seen 
in accordance to the cholestane series. The mass spectrum was also in great agreement 
with their molecular formula which exhibited a very strong molecular ion peak at m/z 
460/462. 
On the basis of the above descriptive discussion, the compound could be suitably 
characterized as 3/?-chloro -2'-amino-5a-cholest-6-eno [6, 5-d] oxazole (157). 
The following mechanism (Scheme-1) has been proposed for the conversion of ketones 
152-154 to the respective products 155-157. 
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CgHp 
X" 
H 
O 
Proton shift 
-H20 
-H + 
(155-157) 
(/ NH2 
X= H. OAc, CI 
Scheme-1 
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'ExperimentaC 
Melting points were determined on a Kofler apparatus and are uncorrected. The IR 
spectra were recorded on KBr pellets with Pye Unicam SP3-100 spectrophotometer and 
its values are given in cm"1. ]H NMR spectra were measured in CDCb on a Bruker DRX-
300 spectrometer at 300 MHz and 13C NMR spectra at 100 MHz, with TMS as internal 
standard and the values are given in ppm (S). Mass spectra were recorded on a JEOL SX 
102/DA-6000 mass spectrometer using Argon/Xenon as the FAB gas. Thin layer 
chromatography (TLC) plates were coated with silica gel G and exposed to iodine 
vapours to check the homogeneity as well as the progress of reaction. Petroleum ether 
refers to a fraction of b.p. 60-80 °C. Sodium sulphate (anhydrous) was used as a drying 
agent. 
Cholest-5-ene: 
3/5-Chlorocholest-5-ene (10 g) was dissolved in warm amyl alcohol (230 mL) and 
sodium metal (20 g) was added in small portions to the solution with continuous stirring 
over a period of 8 h. The reaction mixture was warmed occasionally. When all sodium 
metal was dissolved, the reaction mixture was poured into water, acidified with dilute 
hydrochloric acid and allowed to stand overnight. A white crystalline solid thus obtained 
was filtered under suction and washed thoroughly with water and air dried. 
Recrystallization of the crude material from acetone gave cholest-5-ene in cubes (8.3 g), 
m.p. 93 °C (reported m.p. 89 -91.2 °C).69 
6-Nitrocholest-5-ene: 
A suspension of finely powdered cholest-5-ene (6 g) in glacial acetic acid (50 
mL) was stirred at room temperature for 5 min. and nitric acid (15 mL, d, 1.52) was 
rapidly added followed by the addition of sodium nitrite (3 g) and the stirring was 
continued for further 2 h. The temperature of the reaction mixture was controlled between 
20-25 °C by external cooling. The reaction mixture was then poured into ice cooled 
water. A yellow solid thus obtained was filtered under suction, washed thoroughly with 
water and air dried. Recrystallization from ethanol furnished 6-nitrocholest-5-ene (4.5 g), 
m.p. 119-120 °C (reported m.p. 120-121 °C).70 
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5a-Cholestan-6-one: 
6-Nitrocholest-5-ene (6 g) was dissolved in glacial acetic acid (120 mL) by 
heating and to this solution zinc dust (12 g) was gradually added in small portions with 
shaking. After the initial exothermic reaction had subsided, the suspension was heated 
under reflux for 4 h and water (12 mL) was added during the course of reaction. The 
solution was then filtered and the residue was washed with two (10 mL) portions of warm 
acetic acid. To the filtrate, a few mL of water was added till turbidity developed and it 
was allowed to stand overnight at room temperature. The crystalline material thus 
separated was filtered under suction and washed thoroughly with water in order to 
remove zinc acetate. The organic solid was air dried and then recrystallized from ethanol 
(3.6 g), m.p. 96 -98 °C (reported m.p. 98 -100 °C).66 
Reactions of 5a-cholestan-6-one (152) with urea and iodine: 2'-amino-5a-cholest-6-
eno [6,5-d] oxazole (155): 
To a solution of 5<ar-cholestan-6-one (152) (385 mg) in absolute ethanol (10 mL) 
was added urea (60 mg) and iodine (2 mmol) in the same solvent (25 mL) and the 
reaction mixture was refluxed for about 18 h. The progress of the reaction was monitored 
by TLC. After completion of reaction the excess solvent was removed to three fourths of 
the original volume under reduced pressure. The reaction mixture was suspended in water 
(30 mL) and neutralized with saturated aqueous NaHCC>3 solution and filtered by suction. 
The residue was washed with water, air-dried and then taken in ether. The ethereal layer 
was further washed with water and dried over anhydrous sodium sulphate. Removal of 
solvents gave the crude product which was recrystallized from methanol to give 2'-
amino-5a-cholest-6-eno [6,5-d] oxazole (155), m.p. 115 °C, yield 65 %. 
Analysis found: C, 78.83; H, 10.76; N, 6.54. 
C28H46N20 requires: C, 78.87; H, 10.79; N, 6.57 %. 
IR(KBr):vmax3473(N-H), 1610 (C=C), 1520 (C=N), 1455 (C-N), 1064 cm"1 (C-O). 
'HNMR (CDC13): 6 5.8s (2H, NH2, exchangeable with D20), 5.5br, s (1H, C7-H), 1.13s 
(3H. C10-CH3), 0.72s (3H. Cn-CH3), 0.90 and 0.80 (other methyl protons). 
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13C-NMR (CDCb): S C2' (163), C6 (146.4), C7 (135), C5 (76.2), C3 (19.4), CIO (35.96), 
C18 (11.86), C19 (17.33), C25 (28.08), C26 (21.78), C27 (22.64). 
MS: w/z 426 (M+). 
3/?-Acetoxycholest-5-ene: 
A mixture of cholesterol (50 g), pyridine (75 mL freshly distilled over KOH) and 
freshly distilled acetic anhydride (50 mL) was heated on water bath for 2 h. The resulting 
brown solution was poured into crushed ice water mixture with stirring. A light brown 
solid thus obtained was filtered under suction, washed with water until free from pyridine 
and air dried. The crude product on recrystallization from acetone gave pure 3/S-acetoxy 
cholest-5-ene (45 g), m.p. 113-114 °C (reported m.p. 115- 116°C).71 
3/?-Acetoxy-6-nitrocholest-5-ene: 
To a cooled mixture of 3/?-acetoxycholest-5-ene (10 g) and nitric acid (250 mL; d, 
1.42), sodium nitrite (10 g) was gradually added over a period of 45 min. with continuous 
stirring. Slight cooling was also affected during the course of reaction and stirring was 
continued for additional 2 h. and then cold water (350 mL) was added to the reaction 
mixture. The solid material thus separated was extracted with ether and the ethereal layer 
was washed with water, sodium bicarbonate solution (5 %) (until washing was pink) and 
water and dried over anhydrous sodium sulphate. Removal of the solvent provided 
compound as an oil which was crystallized from methanol to give 3/?-acetoxy-6-
nitrocholest-5-ene (7.0 g) m.p. 104 °C (reported m.p. 102-104 °C).72 
3/#-Acetoxy-5or-choIestan-6-one: 
3/?-Acetoxy-6-nitrocholest-5-ene (6 g) was dissolved in hot glacial acetic acid 
(250 mL) and zinc dust (12 g) was added in small portions with shaking. The suspension 
was heated under reflux for 4 h. and water (12 mL) was added during the course of 
reaction. Zinc dust was removed by filtration and the filtrate was diluted with large 
excess of water. Usual work up of the reaction mixture afforded the ketone, which was 
crystallized from methanol (3.9 g) m.p. 128 °C (reported m.p. 127-128 °C).67 
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Reaction of 3/3-acetoxy-5or-choIestan-6-one (153) with urea and iodine: 3fi-acetoxy -
2'-amino-5a-cholest-6-eno [6,5-d] oxazole (156): 
To a solution of 3/?-acetoxy-5a-cholestan-6-one (153) (444 mg) in absolute 
ethanol (10 mL) was added urea (60 mg) and iodine (2 mmol) in the same solvent (25 
mL) and the reaction mixture was refluxed for about 22 h. The progress of the reaction 
was monitored by TLC. After completion of reaction the excess solvent was removed to 
get three fourths of the original volume under reduced pressure. The reaction mixture was 
suspended in water (30 mL), neutralized with saturated aqueous solution of NaHCCh 
solution and filtered by suction. The residue was washed with water, air-dried and then 
taken in ether. The ethereal layer was further washed with water and dried over 
anhydrous sodium sulphate. Removal of solvents gave the crude product which was 
recrystallized from methanol to give 3/?-acetoxy-2'-amino-5ot-cholest-6-eno [6,5-d] 
oxazole (156), m.p. 79 °C, yield 80 %. 
Analysis found: C, 74.35; H, 9.89; N, 5.76 
C30H48N2O3 requires: C, 74.38; H, 9.91; N, 5.78 %. 
IR (KBr): vmax 3435 (N-H), 1735 and 1299 (OCOCH3), 1620 (C=C), 1520 (C=N), 1455 
(C-N), 1045 cm"1 (C-O). 
'H-NMR (CDCI3): S 5.8s (2H, NH2, exchangeable with D20), 5.5br, s (1H, C7-H), 4.7m 
(1H, C3a-H, Wl/2=15 Hz), 2.01s (3H, OCOCH3), 1.12s (3H, C0-CH3), 0.71s (3H, C!3-
CH3), 0.92 and 0.85 (other methyl protons). 
13C-NMR (CDCI3): S OCOCH3 (170.1), C2' (163), C6 (146.2), C7 (122), C5 (70.2), C3 
(68.9), C9 (51.04), C10 (35.08), C18 (11.83), C19 (17.10), C25 (28.07), C26 (22.63), 
C27 (22.63). 
MS: m/z 484 (M+). 
3/?-Chlorocholest-5-ene: 
Freshly purified thionyl chloride (75 mL) was added gradually to cholesterol (100 
g) at room temperature. A vigorous reaction ensued with the evolution of gaseous 
products. When the reaction slackened, the mixture was gently heated at the temperature 
of 50-60 °C on a water bath for 1 h and then poured onto crushed ice-water mixture with 
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stirring. The yellow solid thus obtained was filtered under suction and washed several 
times with ice cooled water and air dried. Recrystallization of crude product from acetone 
gave 3/?-chlorocholest-5-ene (94 g), m.p. 95-96 °C (reported m.p. 96-97 °C).73 It gave 
positive Beilstein test and a yellow colour with tetra-nitromethane in chloroform. 
3/J-Chloro-6-nitrochoIest-5-ene: 
To a well stirred mixture of 3/?-chlorocholest-5-ene (14 g), glacial acetic acid 
(100 mL) and nitric acid (28 mL, d, 1.52) at temperature below 20 °C, was added sodium 
nitrite (3.0 g) gradually over a period of 2 h. After complete addition of sodium nitrite, 
the mixture was further stirred for an additional period of 1 h. Now Ice cooled water (200 
mL) was added to it and the yellowish solid thus separated was filtered and air dried. The 
desired product was recrystallized from methanol as needles (8.9 g), m.p. 151-152 °C 
(reported m.p. 153 °C).74 
3yS-Chloro-5a-cholestan-6-one: 
A mixture of 3/?-chloro-6-nitrocholest-5-ene (12 g) and glacial acetic acid (240 
mL) was heated just to get a clear solution. The zinc dust (24 g) was added gradually in 
small portions with constant shaking. The suspension was heated under reflux for 4 h. 
and water (24 mL) was added at regular intervals during the course of reaction. The hot 
solution was poured into ice-cold water. The organic matter was extracted with ether and 
ethereal solution was washed successively with water, sodium bicarbonate solution (5 %) 
and again with water and dried over anhydrous sodium sulphate. Evaporation of the 
solvent furnished the ketone as an oil which was crystallized from methanol (8.7 g), m.p. 
128-129 °C (reported m.p. 129 °C).68 
Reaction of 3/3-chloro-5a-cholestan-6-one (154) with urea and iodine: 3p~chloro -2'-
amino-5a-cholest-6-eno [6,5-d] oxazole (157): 
To a solution of 3/?-chloro-6-nitrocholest-5-ene (154) (419 mg) in absolute 
ethanol (10 mL) was added urea (60 mg) and iodine (2 mmol) in the same solvent (25 
mL) and the reaction mixture was refiuxed for about 20 h. The progress of the reaction 
was monitored by TLC. After completion of reaction the excess solvent was removed to 
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three fourths of the original volume under reduced pressure. The reaction mixture was 
suspended in water (30 mL) and neutralized with saturated aqueous NaHC03 solution 
and filtered by suction. The residue was washed with water, air-dried and then taken in 
ether. The ethereal layer was further washed with water and dried over anhydrous sodium 
sulphate. Removal of solvents gave the crude product which was recrystallized from 
methanol to give 3/?-chloro -2'-amino-5ct-cholest-6-eno [6,5-d] oxazole (157), m.p. 80 °C, 
yield 60 %. 
Beilstein positive 
Analysis found: C, 72.99; H, 9.74; N, 6.05. 
C28H45N2OCI requires: C, 73.04; H, 9.78; N, 6.08%. 
IR (KBr): vmax 3440 (N-H), 1610 (C=C), 1510 (C=N), 1450 (C-N), 1055 (C-O), 710 
cm^C-Cl). 
'HNMR (CDCI3): 6 5.9s (2H, NH2, exchangeable with D20), 5.2br, s (IH, C7-H), 3.9m 
(IH, C3-«H, Wl/2=17 Hz), 1.11s (3H, C,0-CH3), 0.71s (3H, C13-CH3), 0.91 and 0.82 
(other methyl protons). 
13C NMR (CDCI3): 6 C2' (155), C6 (146.2), C7 (125), C5 (70.2), C3 (59.6), C9 (51.51), 
C10 (35.79), C18 (11.82), C19 (16.98), C25 (29.81), C26 (22.65), C27 (21.98). 
MS: m/z 460/462 (M+). 
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CHAPTEE-4 
Steroidal'9/Lercapto 
(DiazoCine 
Theoretical 
Since many drugs contain the diazoline nucleus, the class has been studied and the field 
continues to be active today. Diazoline containing compounds are used as anti-histamine 
free of both sedative (calming) and hypnotic effects. 
Padmavathi et al.x synthesized 2,6-diphenyl-4H-pyran (5'-amino-3'-
hydroxypyrimidin)-l'-one (2) and 2,6-diphenyl-4H-pyran (5'-amino-3'-
mercaptopyrimidin)-l'-one (3) by refluxing 2,6-diphenyl-4-cyano-4-ehoxy carbony-4H-
pyran (1) with urea and thiourea in the presence of 10% sodium ethoxide. 
NC C02Et 
Urea/NaOEt Thiourea/ 
"NaOEt 
They also reported the synthesis of spiro [5.5J-2, 6-diphenyl-4H-pyran 
(pyrimidine)-l', 3', 5'-trione (5) and spiro [5.5]-2, 6-diphenyl-4H-(pyrimidine)-3'-thioxo-
1', 5'-dione (6) by the reaction of 2, 6-diphenyl-4, 4-dimethoxycarbonyl-4H-pyran (4) 
with urea and thiourea in the presence of 10% sodium methoxide. 
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Me02C C02Me 
Ar' O' 
(4) 
^Ar 
Thiourea/ 
NaOMe 
Demirbas' synthesized 5-alkyl-2-[(5-mercapto-l, 3, 4-thiadiazol-2-yl) methyl]-2, 4-
dihydro-3//-l, 2, 4-triazo!-3-one derivatives (10-12) by the treatment of 2-[(5-chloro-
1,3,4-thiadiazol-2-yl)methyl]-5-methyl-2,4-dihydro-3//-1,2,4-triazoI-3-one derivatives 
(7-9) with thiourea. 
N N N- -N 
N-
R' 
H 
(7-9) 
-N CI SH 
O 
Thiourea 
R 
(7,10) CH3 
IN — 
(8,11)CH2C6H5 
(9,12) C6H5 
IN 
H 
(10-12) 
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Khodairy reported the treatment of 2,9-dihydrazinobipyrimidino(2,3-b) thienothiophene 
(13) with CS2 and malononitrile or ethyl cyanoacetate in 1:1:1 molar ratio under PTC 
[K2C03/DMF/tetrabutylammonium bromide (TBAB)] to give the corresponding (3-
mercapto-4-cyano(carbethoxy)-5-aminopyrazol-2-yl)thieno(3,2-d)pyrimidine derivative 
(14). 
HS SH 
H2NHN^ ,N^ 
PKN, 
0 
NHNH, 
CS, 
NPh malononitrile NH, PhN 
I 
NPh NH2 
O 
(13) (14) 
El-Emary synthesized 5-(6-amino-3-methyl-l-phenyl-1 H-pyrazolo[3,4-b]pyrazin-5-yl)-
3H-[l,3,4]oxadiazole-2-thiol (16) by heating 6-amino-3-methyl-l-phenyl-1H-
pyrazolo[3,4-b]pyrazin-5-carbohydrazide (15) with carbon disulphide in pyridine for 3 
days at 50 °C 
H3C 
N. 
N /CONHNH2 
'N N 
I 
Ph 
(15) 
NH2 
CS2 
Pyridine 
N N 
O SH 
(16) 
Sayed reported the synthesis of quinazoline thione derivatives (21-24) by the reaction of 
17-20 with thiourea. 
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Ar-— HC. 
Ar Thiourea
 > 
(17-20) (21-24) 
(17) Ar -Ar1 =C6H5, X=X* -CH3 (21) Ar =Ar' =C6H5, X- X1 =CH; 
(18) Ar =Ar' =C6H5, X=H, X1 = QFU-p-Br (22) Ar =Ar' =C6H5, X= H, X1 = C6H4-/?-Br 
(19) Ar =Ar" =C6H4-/>OCH3, X=X' =CH3 (23) Ar =Ar' =C6H4-/>OCH3, X=X' =CH3 
(20) Ar =Ar' =C6H4-/?-OCH3, (24) Ar =Ar' =C6H4-p-OCH3, 
X=H, X'=C6H4-p-Br X=H, X1 =C6H4-p-Br 
Dandia et al6 prepared spiro [3H-indole-3, 4' (3'H)-pyrimidine]-2 (lH)-one (26) and 1, 
3-diazepino [4, 5-b] indole-2-thione/one (27) by the reaction of 1, 3-dihydro-3-(2-phenyl-
2-oxoethylidine)-2H-indole-2-ones (25) with urea/ thiourea. 
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(25) 
X= CI.CH3 
R=H, F 
Y=S,0 
NH2CONH2/ NH2CSNH2 
(26) 
X = CI, CH3 
Y = 0,S 
R = H, F 
(27) 
Similarly l,3-dihydro-3-(2-phenyl-2-oxoethylidene)-2H-indole-2-ones (28) reacted with 
phenylurea/ phenylthiourea to give spiro [3H-indole-3,4' (3'H)-pyrimidine]-2 (lH)-ones 
(29).6 
R X 
C6H5NHCONH2 
C6H5NHCSNH2 
(28) (29) 
117 
Butler and Hussain7 reported the cyclization of arylaldehyde (30) with thiourea or urea to 
give cyclic triazines (31). 
i H 
R ' C H O U r ea / Thiourea^ 
HNL NH 
O/S 
(30) (31) 
Al-Hajjar and coworkers8 reported the synthesis of pyrimidine-2-(lH)-thione-(33) by the 
reaction of carbonyl compounds (32) with thiourea in presence of NaOEt. 
- ^ / ^ / R l 
R - C H ^ C H - C O - R 1 Thiourea 
NaOEt 
(32) 
Baddar et al9 reported the synthesis of 4, 6-diphenylpyrimidine-2-thione (35) 4, 6-
diphenyl-2- (IH) pyrimidin-one (36) by the reaction of benzoylphenylacetylene (34) with 
thiourea and urea in the presence of sodium ethoxide. 
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o 
II 
C6H5 
C6H5—C=C-C-C6H5 Thiourea 
(34) 
Urea 
C6H5 C6H5 
CeHs 
10 Mahadevan et al. prepared 6-(2-naphtho [2, l-b]furyl)-2, 4-dioxo-l, 2, 3, 4, 5,-
pentahydropyrimidine (38) and 6-(2-naphtho [2, l-b]furyl)-4-oxo-2-thioxo-l, 2, 3, 4, 5,-
pentahydropyrimidine (39) by the treatment of ethyl (2-naphtho[2,l-b]furyl) acetate (37) 
with urea and thiourea in the presence of sodium ethoxide. 
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(37) 
NH9CONH, 
EtONa 
C-CH2-C-OC2H5 
O 
O' 
,0 
N ,NH 
(38) 0 
NH2CSNH2 EtONa 
(39) S 
Shamsuzzaman et al.u prepared steroidal ketone thiosemicarbazones 43-45 by the 
reaction of steroidal ketones 40-42 with thiosemicarbazide. Compounds 43-45 on 
oxidative cyclization with H202 at 0 °C provided steroidal spiro-l', 2', 4'-triazolidine-3-
thiones (46-48). 
Steroidal spiro-l, 2', 4'-triazolidine-3-thiones (46-48) were also obtained by the 
oxidative cyclization of steroidal thiosemicarbazones (43-45) with m-CPBA.1" 
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CgHn C8H,7 
NH2NHCSNH2 
R 
(40) H 
(41) CI 
(42) OAc 
NNHCSNH2 
R 
(43) H 
(44) CI 
(45) OAc 
H202 
or 
w-CPBA 
CgHn 
R 
(46) H 
(47) CI 
(48) OAc 
Mohan and Kumar13 synthesized 2, 3-dihydro-7-methyl-5H-as-triazino [5, 6-b] indole-3-
thione (50) by the reaction of 6-methylisatin-3-thiosemicarbazone (49) in the presence of 
4% KOH solution. 
121 
NNHCSNH2 
(49) (50) 
Mohan et al.14 reported the synthesis of 2, 3-dihydro-8-isopropyl-5H-as-triazino[5,6-b] 
indole-3-thione (52) by the base catalyzed cyclization of 5-isopropylisatin-3-
thiosemicarbazone (51) in the presence of KOH solution. 
NNHCSNH2 
KOH 
(51) (52) 
Islam et al}5 reported the oxidative cyclization of adamantanone thiosemicarbazone (53) 
with H202 at room temperature to give adamntane-5-spiro-4-(o-methoxyphenyl)-l', 2', 4'-
triazolidine-3'-thione (54). 
NNHCSNHR' 
H,0 2 u 2 
(53) (54) 
Landquist16 reported the oxidative cyclization of 4-methyl thiosemicarbazones of 
androstan-3. 17-dione (55) with AI2O3 which gave 17-oxo-5oc-androstan-3-spiro-3'-(4'-
methyO-A1 1', 2', 4'-triazoIine-3'-thione (56). 
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MeHNSCHNN 
A1203 
(55) (56) 
Islam et al17 prepared 1, 2, 4-triazolidine-3-thiones (58) by the oxidative cyclization of 
compound 57 with H2O2. 
RN P1 
R 
R' 
>=NNH-CSNHRZ H9O 2^2 HN NH 
J NH 
(57) (58) 
Schantl et al{% reported the reaction of compound 59 with potassium cyanate and 
potassium thiocyanate (60) which provided triazolidinones 61 and triazolidine thiones 62 
respectively. 
RnC6H5.nNHN-CMe2 + KZCN + RnC6H5.n< 
H 
N NH 
N-
H 
(59) 
Z 
(60) (61) O 
(62) S 
Osman et aliy reported the reaction of hydrazine hydrate (63) with thiourea (64) to give 
4-amino-3-thio-l, 2,"4-triazolidine (65). 
19 
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H2N 
NH2-NH2 + H2NCSNH2 
N NH 
—NH 
(63) (64) (65) 
Cyclocondensation of 2, 4-disubstituted thiosemicarbazide 66 with ethyl methyl ketone 
(67) gave 5-ethyl-4-methylallyl-5-methyl-2-(4-methyl phenyl)-l,2,4-triazolidine-3-thione 
(68) 20 
Me 
NIVNRCSNHR1 + V=o 
Et7 
(66) (67) 
S-
Me-
NR 
R1 S 
(68) 
Arai et al21 reported the reaction of hydrazinium thiocyanate (69) with aldehydes or 
ketones which gave 3, 3-dialkyl-l, 2, 4-triazolidine-5-thione (70) along with triazole 
compound 71. 
R R1 S 
NH2-NH2HCSN + 
R 
R 
O 
(69) 
R 
H 
N NH 
R N-
H V 
(70) 
HN N NH 
HN. .N-
(71) 
Martvov et al."" carried out the reaction of compound (72) with CSCI2 to yield 1, 2, 4-
triazolidine-3-thione (73). 
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(72) (73) 
X, Y, Z = H, Me, OMe, N02, CI, Br, 
R'= Me, H 
R2= Me, C6H3 (N02)2-2, 4 
Zelenin et al.2i reported the cyclization of thiosemicarbazones 74 in acidic medium to 
give derivatives of 1, 2, 4-triazolidine-3-thiones (75) and 1, 3, 4-triazolidines (76). 
RN NH RN NH 
Me Me^C^NNRCSCSNHR
1 
(74) 
-
HN 
N 
H 
(75) 
\ 
Me S 
(76) 
Me 
Me 
Klaus et al2A reported the chemoselective reaction of thiosemicarbazide 77 with 
aldehydes and ketones. With aldehydes it gave thiosemicarbazones whereas with ketones 
it provided triazolidine thiones (78). 
R \ 
RN(NH2)CSNHCH2CMe=CH2 + > = 0 
R 2 / 
(77) 
H 
R1 N — NR 
R N — 
I 
CH2 
I 
% £ 
MeC=CH2 
(78) 
Islam et al25 reported the acylation of 5a-cholestan-3-one thiosemicarbazone (79) with 
acetic anhydride to give 5a-cholestan-3-s/?/ro-3-[4'-acetyl-2'-acetylamino]-A -T, 3', 4'-
thiadiazoline (80). 
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H2NSCHNN 
QH 8"17 
Ac20 Ac 
-*• N - N 
AcHN' 
(79) (80) 
Raphael et al. reported the alkali catalyzed thermal cyclization of 1-alkyl and 1, 6-
dialkyl-2, 5-dithiobiureas (81) which gave 4-alkyl-l, 2, 4-triazolidine-3, 5-dithiones (82) 
and 2-alkylamino-A2-l, 3, 4-thiadiazoline-5-thiones (83). 
H H 
N - N 
SNH 
I 
R 
(81) 
NHR1 NaOH 
H 
N — N H 
N-
I 
R 
- f RHN-
V 
(82) 
N —NH 
Y V 
(83) 
Chande et al21 reported l-phenyl-4-alkyl/aryl-5-thio-l, 2, 4-triazolidine-3-one (85) by 
the reaction of benzyl-/?-phenyl-thiocarbazinate (84) with alkyl/aryl isothiocyanate. 
O O 
n RNCS; II 
RNHCSNPhNHCSCH2Ph *-
S" 
PhNHNHCSCH7Ph 
i) S 
ii)H+ 
(84) 
PhN- -NH 
N 
H 
(85) 
O 
Trisubstituted 1, 2, 4-triazolidine-3-thiones (87) were prepared by the pyrolysis of 
disubstituted 1. 2, 4-triazolidine-3-thiones (86).28 
HN NR 
R 1 1 1 —> 
N- NR 
R" N ' H 
(86) 
RA N 
R1 
(87) 
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Zelenin ct al." reported the reaction of ketones 88 with 1, 2, 4-trimethyl 
thiosemicarbazide (89) in the presence of trifluoroacetic acid which provided substituted 
1, 2, 4-triazolidine-3-thiones (90). 
Ri MeN NMe 
; 0 + MeNHNMeCSNHMe C F 3 C Q Q H ^
 Ri 
Rz 
Rz 
(88) (89) 
N 
H 
(90) 
The reaction of acetone methyl hydrazone (91) with potassium isothiocyanate provided 1, 
5, 5-trimethyl-l, 2, 4-triazolidine-3-thione (92).30 
Me \ 
Me-
,C=NNHMe KNCS 
M X 
H 
N-
Me N NH 
Me 
(91) (92) 
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(Discussion 
The derivatives of thiourea have been prepared by the process of cyclocondensation, in 
which thiourea condensed with steroidal and non-steroidal carbonyl compounds under 
different reaction conditions. Thiourea and urea have been used as purification agents for 
the effluent of organic, inorganic, industrial, agricultural and mining waste31. These 
compounds were also known to possess anti-diabetic activity32. A few compounds of 
thiourea have showed bactericidal, fungicidal, herbicidal and algicidal activities33,34. It 
was described that 5'-[w-(carboxamidino) alkyl]-isothiourea act as radiation protector in 
mammalian skin35. Some other thiourea derivatives such as O-allylthioureido benzoic 
acid also showed radioprotective effect36 to the phytohormones and in the yeast 
Schizosaccharomyces prombe.31'38 The therapeutic importance of these derivatives of 
thiourea encouraged us to undertake the synthesis of some reactions of thiourea with 
steroidal dibromides. The substrates selected for initial studies include 3/?-hydroxy-5,6/?-
dibromo-5«-cholestane (93) 39, 3/?-acetoxy-5,6/?-dibromo-5a-cholestane (94) and 3/9-
chloro-5,6/?-dibromo-5a-cholestane (95)39. The products, steroidal mercapto diazolines 
have been characterized on the basis of their elemental analysis and spectral (IR, H-
NMR, 13C-NMR, MS) studies. 
Br Br 
X 
(93) OH 
(94) OAc 
(95) CI 
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Reaction of 3/?-hydroxy-5, 6/?-dibromo-5a-cholestane (100) with thiourea 
A solution of dibromide (93) in absolute ethanol and thiourea was refluxed for 8 
h. Progress of the reaction was monitored by the thin layer chromatography. After 
completion of reaction, the reaction mixture was concentrated under reduced pressure. 
Usual work up, purification by column chromatography and recrystallization from 
acetone provided compound 96, m.p. 110 °C. 
HS 
(93) (96) 
Characterization of the compound, m.p. 110 °C as 3/?-hydroxy-5a-cholestan-2'-
mercapto- [6, 5-d]-l', 3'-diazoIine (96): 
The compound 96 was correctly analyzed for molecular formula C28H48N2OS. 
Negative Beilestein test showed complete removal of bromine. The IR spectrum 
exhibited characteristic absorption bands at 3389.9 and 3200 cm"1 which indicated the 
presence of NH and OH group respectively. A weak absorption band at 2552 cm" was 
assigned for SH stretching and other bands at 1054 and 1235 cm"1 for C-0 and C-S group 
respectively. The bands at 1653 and 1374 cm"1 were due to C=N and C-N stretching 
respectively. Further, evidence for the formation of structure 96 was well supported by its 
'H NMR and 13C NMR. It's *H NMR spectrum exhibited one proton singlet at 3 7.2 for 
NH (exchangeable with D20), another singlet for one proton at 3 5.3 assignable to SH 
group (exchangeable with D2O). Hydroxy! proton appeared at 3 4.8 (exchangeable with 
D20). A distorted double doublet for one proton appeared at 3 3.7 which could be 
attributed for Ce-fM. Other important peaks for angular and side chain methyl protons 
were observed at 3 1.12, 0.93, 0.85 and 0.67. 13C NMR spectrum of the compound also 
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supported the proposed structure and displayed characteristic signals at S C2' (140), C3 
(58), C6 (121), C5 (76). Remaining carbon atoms are seen in accordance to the 
cholestane series. Additional support was provided by its mass spectrum which gave a 
prominent molecular ion peak at tn/z 460 
Thus, on the basis of the above descriptive discussion, the compound 96 can be 
suitably characterized as 3/?-hydroxy-5a-cholestan-2'-mercapto-[6, 5-d]-l', 3'-diazoline. 
Reaction of 3/?-acetoxy-5, 6/?-dibromo-5#-choIestane (94) with thiourea 
3/?-Acetoxy-5, 6/?-dibromo-5a-cholestane (94) was added to absolute ethanol 
followed by thiourea. The reaction mixture was refluxed for 12 h. After completion of 
reaction it was usually worked up, purified by column chromatography and recrystallized 
from acetone which gave compound 97, m.p. 156 °C. 
(94) (97) 
Characterization of the compound, m.p. 156 °C as 3/?-acetoxy-5a-cholestan-2'-
mercapto [6, 5-d]-l', 3'-diazoline (97): 
The elemental analysis of the compound 97 corresponded to the molecular 
formula C30H50N2O2S. Negative Beilestein test showed complete removal of bromine. 
The IR spectrum exhibited characteristic absorption bands at 3395, 1737, 1236, 1273, 
2680, 1670 and 1376 cm"1. The band at 3395 was assigned to NH group. Strong bands at 
1737 and 1236 were due to acetate group, other important bands at 1670, 1376 and 1273 
were due to O N , C-N and C-S stretchings respectively, another band at 2680 cm" was 
attributed to SH stretching. The 'H-NMR spectrum lent it support in favour of compound 
97 in a broad way. The spectrum displayed a singlet integrating for a proton at S 7.3 
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indicating the presence of NH proton (exchangeable with D20), another singlet for one 
proton at 6 5.3 assignable to SH group (exchangeable with D20). A multiplet was 
observed at S 4.6 (Wm = 16 Hz, axial) which could be assigned to C3-a proton. The 
spectrum also displayed a sharp singlet for three protons at S 2.03 which could be 
attributed to the acetate group protons. A distorted double doublet for one proton 
appeared at S 3.5 which could be attributed for C6-/?H. Angular and side-chain methyl 
protons were appeared at S 1.11, 0.94, 0.87 and 0.67 indicating the presence of steroidal 
skeleton. 13C NMR spectrum of the compound also supported the proposed structure and 
displayed characteristic signals at 8 C2' (140), C3 (71), C5 (76), C6 (121). Remaining 
carbon atoms are seen in accordance to the cholestane series. Additional support was 
provided by its mass spectrum which gave a prominent molecular ion peak at m/z 502 
On the basis of above studies and its analogy with earlier compound 96 this can 
be best characterized as 3/?-acetoxy-5a-choIestan-2'-mercapto-[6, 5-d]-l', 3'-diazoline 
(97). 
Reaction of 3/?-chloro-5, 6/?-dibromo-5a-cholestane (95) with thiourea 
3/?-Chloro-5, 6/?-dibromo-5a-cholestane (95) was added to absolute ethanol 
followed by thiourea. The reaction mixture was refluxed for 10 h. Progress of the reaction 
was monitored by the thin layer chromatography. After completion of reaction, the 
reaction mixture was concentrated under reduced pressure. Usual work up, purification 
by column chromatography and recrystallization from acetone provided compound 98, 
m.p. 98 °C. 
HS 
(95) (98) 
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Characterization of the compound, m.p. 98 °C as 3/?-chIoro-5a-cholestan-2'-
mercapto- [6, 5-d]-l', 3'-diazoline (98): 
The compound 98 was correctly analyzed for molecular formula C28H47N2SCI. 
The IR spectrum showed characteristic absorption peaks at 3380 and 2580 cm"1 which 
indicated the presence of NH and SH groups respectively. The bands at 1666, 1376 and 
1236 were due to C=N, C-N and C-S stretchings respectively, another band at 719 cm"1 
was attributed to C-Cl. Its 'HNMR spectrum displayed a singlet integrating for one 
proton at S 7.2, which was assigned to NH proton (exchangeable with D2O), another 
singlet for one proton at 6 5.3 assignable to SH group (exchangeable with D2O). C3-(aH) 
axial proton appeared at d 3.9 (W]/2 = 15 Hz) as a broad multiplet. A distorted double 
doublet for one proton appeared at S 3.5 which could be attributed for Ce-flH. Angular 
and side-chain methyl protons were appeared at 5 1.14, 0.97, 0.87 and 0.67. 13C NMR 
spectrum of the compound also supported the proposed structure and displayed 
characteristic signals at d C2' (140), C3 (60), C5 (77), C6 (121). Remaining carbon atoms 
are seen in accordance to the cholestane series. Additional support was provided by its 
mass spectrum which gave a prominent molecular ion peak at m/z 478/480. 
Thus, on the basis of the above descriptive discussion, the compound can be 
suitably characterized as 3/?-chloro-5a-cholestan-2'-mercapto- [6, 5-d]-l', 3'-diazoline 
(98). 
Formation of steroidal mercapto diazolines 96, 97 and 98 under the condition case 
may be shown according to the proposed mechanism (Scheme 1). This may be taken as 
tentative to establish the mechanism of reaction. 
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Br 
Br 
NH,CNH-, 
==-»-
(-HBr) X 
(96, 97, 98) 
X = OH, OAc, CI 
Scheme-1 
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(E^perimenta[ 
Melting points were determined on a Kofler apparatus and are uncorrected. The IR 
spectra were recorded on KBr pellets with Pye Unicam SP3-100 spectrophotometer and 
its values are given in cm'1. *H NMR spectra were measured in CDC13 on a Bruker DRX-
300 spectrometer at 300 MHz and 13C NMR spectra at 100 MHz, with TMS as internal 
standard and the values are given in ppm (S). Mass spectra were recorded on a JEOL SX 
102/DA-6000 mass spectrometer using Argon/Xenon as the FAB gas. Thin layer 
chromatography (TLC) plates were coated with silica gel G and exposed to iodine 
vapours to check the homogeneity as well as the progress of reaction. Petroleum ether 
refers to a fraction of b.p. 60-80 °C. Sodium sulphate (anhydrous) was used as a drying 
agent. 
3/?-Hydroxy-5, 6/?-dibromo-5a-cholestane (93): 
To a solution of cholesterol (5 g) in ether (30 mL) was added bromine solution (0.9 
mL of bromine in 20 mL of glacial acetic acid containing 0.2 g of anhydrous sodium 
acetate) with continuous stirring below 20 °C. The solution turned yellow and promptly 
set to a stiff paste of the dibromide. The mixture was cooled in an ice bath and stirred 
with a glass rod to ensure complete crystallization. The product was then collected by 
filtration under suction and washed with cold ether-acetic acid mixture (3:7) until the 
filtrate was completely colourless and then air dried (6.9 g), m.p. 112 °C (reported, m. p. 
113°C).39 
Reaction of 3/?-hydroxy-5, 6/?-dibromo-5a-cholestane (93) with thiourea: 5/?-
hydroxy-5a-cholestan-2'-mercapto-[6, 5 dj-l', 3'-diazoline (96): 
3/?-Hydroxy-5, 6/?-dibromo-5«-cholestane (93) (546 mg) was added to absolute 
ethanol (30 mL) followed by thiourea (76 mg). The reaction mixture was refluxed for 8 h. 
Progress of the reaction was monitored by the thin layer chromatography. After 
completion of reaction, the reaction mixture was concentrated under reduced pressure. 
The residue was taken in diethyl ether, washed twice with water and dried over 
anhydrous sodium sulphate. Removal of solvent gave the crude product which was 
purified by column chromatography (petroleum ether-diethyl ether, 19:1) and 
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recrystallized from acetone to give 3/?-hydroxy-5ec-cholestan-2'-mecapto-[6, 5-d]-l', 3'-
diazoliine (96), m.p. 110 °C, yield 80 %. 
Analysis found: C, 73.07; H, 10.45; N, 6.11 
C28H48N2OS requires: C, 73.04; H, 10.43; N, 6.08%. 
IR (KBr): vmax 3389.9 (-NH), 3200 (-OH), 2552 (-SH), 1653 (ON), 1374 (C-N), 1235 
(C-S), 1054cm"I(C-O). 
'H-NMR (CDC13): S 7.2s (1H, NH, exchangeable with D20), 5.3s (1H, SH, exchangeable 
with D20), 4.8s (1H, OH, exchangeable with D20), 3.7dd (1H, C6-y9H), 1.12s (3H, C10-
CH3), 0.67s (3H, C13-CH3) 0.93 and 0.85 (other side chain methyl protons). 
13C-NMR (CDCI3): 6 C2' (140), C6 (121), C3 (58), C4 (38.56), C5 (76), C7 (33.03), C8 
(32.83), C9 (51.68), C10 (35.96), C18 (11.86), C19 (17.33), C25 (28.08), C26 (21.78), 
C27 (22.64). 
MS: m/z 460 (M+). 
3/?-Acetoxycholest-5-ene: 
A mixture of cholesterol (50 g), pyridine (75 mL freshly distilled over KOH) and 
freshly distilled acetic anhydride (50 mL) was heated on water bath for 2 h. The resulting 
brown solution was poured into crushed ice water mixture with stirring. A light brown 
solid thus obtained was filtered under suction, washed with water until free from pyridine 
and air dried. The crude product on recrystallization from acetone gave pure 3/?-acetoxy 
cholest-5-ene (45 g), m.p. 113 -114 °C (reported m.p. 115-116 °C).41 
3/?-Acetoxy-5, 6/?-dibromo-5«-cholestane (94): 
To a solution of 3/?-acetoxycholest-5-ene (2.9 g) in ether (30 mL) was added 
bromine solution (0.9 mL of bromine in 20 mL of glacial acetic acid containing 0.2 g of 
anhydrous sodium acetate) with continuous stirring below 20 °C. A white solid formed 
which was filtered under suction and washed thoroughly with cold diethyl ether-acetic 
acid (3:7) mixture. The dried dibromide was recrystallized from acetone with traces of 
ethyl acetate and methanol, m.p. 115-117 °C (reported m.p. 114-118 °C).40 
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Reaction of 3/?-acetoxy-5, 6/?-dibromo-5a-choIestane (94) with thiourea: 3(l-acetoxy-
5a-cholestan-2'-mercapto-[6, 5-dJ-l', 3'-diazoline (97): 
To a solution of 3/?-acetoxy-5, 6/?-dibromo-5a-cholestane (94) (604 mg) in absolute 
ethanol (30 mL) was added thiourea (76 mg) and then reaction mixture was refluxed for 
12 h. Progress of the reaction was monitored by the thin layer chromatography. After 
completion of reaction, the reaction mixture was concentrated under reduced pressure. 
The residue was taken in diethyl ether, washed twice with water and dried over 
anhydrous sodium sulphate. Removal of solvent gave the crude product which was 
purified by column chromatography over silica gel. Elution with petroleum ether-diethyl 
ether (19:1) gave the crude product as 3/?-acetoxy-5a-cholestan-2'-mercapto-[6, 5-d]-l', 
3'-diazoline (97), which was recrystallized from acetone, m.p. 156 °C, yield 75 %. 
Analysis found: C, 71.69; H, 9.93; N, 5.56 
C3oH5oN202S requires: C, 71.71; H, 9.96; N, 5.57 %. 
IR (KBr): vmax 3389.9 (-NH), 1737 and 1236 (CH3COO), 2680 (-SH), 1670 (C=N), 1273 
(C-S), 1376cm"'(C-N). 
'H-NMR (CDC13): 6 7.3s (1H, NH, exchangeable with D20), 5.3s (1H, SH, exchangeable 
with D20), 4.6m (1H, C3-aH, W,/2 16 Hz), 3.8dd (1H, C6-/?H), 2.03s (3H, CH3COO), 
1.11s (3H, C0-CH3), 0.67s (3H, C,3-CH3) 0.94 and 0.87 (other side chain methyl 
protons). 
13C-NMR (CDCb): S C2' (140), C6 (121), CH3COO (171.61), C3 (71), C4 (39.84), C5 
(76), C7 (32.53), C8 (35.72), C9 (51.04), C10 (35.08), C18 (11.83), C19 (17.10), C25 
(28.07), C26 (22.63), C27 (22.63). 
MS: m/z 502 (M+). 
3/?-ChIorochoIest-5-ene: 
Freshly purified thionyl chloride (75 mL) was added gradually to cholesterol (100 
g) at room temperature. A vigorous reaction ensued with the evolution of gaseous 
products. When the reaction slackened, the mixture was gently heated at the temperature 
of 50-60 °C on a water bath for 1 h and then poured onto crushed ice-water mixture with 
stirring. The yellow solid thus obtained was filtered under suction and washed several 
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times with ice cooled water and air dried. Recrystallization of crude product from acetone 
gave 3/?-chlorocholest-5-ene (94 g), m.p. 95-96 °C (reported m.p. 96-97 °C).42 It gave 
positive Beilstein test and a yellow colour with tetra-nitromethane in chloroform. 
3/?-Chloro-5, 6/?-dibromo-5a-cholestane (95): 
To a solution of 3/?-chlorocholest-5-ene (2.0 g) in ether (30 mL) was added 
bromine solution (0.9 mL of bromine in 20 mL of glacial acetic acid containing 0.2 g of 
anhydrous sodium acetate) with continuous stirring below 20 °C. A white solid formed 
which was filtered under suction and washed thoroughly with cold diethyl ether-acetic 
acid (3:7) mixture. Recrystallization of the dried solid below 30 °C with ethyl acetate 
i n 
acetone provided pure dibromide, m.p. 133 °C (reported m.p. 134-135 °C). 
Reaction of 3/?-chloro-5, 6/?-dibromo-5a-choIestane (95) with thiourea: 3fl-chloro-5a-
cholestan-2'-mercapto-[6, 5-dJ-l', 3'-diazoline (98): 
To a solution of 3/?-chloro-5, 6/?-dibromo-5a-cholestane (95) (2.82 g) in absolute 
ethanol (30 mL) was added thiourea (400 mg), then reaction mixture was refluxed for 10 
h. Progress of the reaction was monitored by the thin layer chromatography. After 
completion of reaction, the reaction mixture was concentrated under reduced pressure. 
The residue was taken in diethyl ether, washed twice with water and dried over 
anhydrous sodium sulphate. Removal of solvent gave the crude product which was 
purified by column chromatography over silica gel. Elution with petroleum ether-diethyl 
ether (15:1) gave the crude product as 3/?-chloro-5a-cholestan-2'-mercapto- [6, 5-d]-l', 
3'-diazoline (98), which was recrystallized from acetone, m.p. 98 °C, yield 65 %. 
Beilstein positive 
Analysis found: C, 70.26; H, 9.79; N, 5.81 
C28H47N2SCI requires: C, 70.29; H, 9.83; N, 5.85 %. 
IR (KBr): vmax 3389.9 (-NH), 2580 (-SH), 1666 (C=N), 1376 (C-N), 1236 (C-S), 719 cm"1 
(C-Cl). 
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'H-NMR (CDCI3): S 7.2s (IH, NH, exchangeable with D20), 5.3s (IH, SH, exchangeable 
with D20), 3.9m (IH, C3-«H, W1/2 15 Hz), 3.5dd (IH, C6-/?H), 1.14s (3H, C10-CH3), 
0.67s (3H, C13-CH3), 0.97 and 0.87 (other side chain methyl protons). 
13C-NMR (CDCI3): 8 C2' (140), C6 (121), C3 (60), C4 (39.64), C5 (77), C7 (32.66), C8 
(32.83), C9 (51.51), CIO (35.79), C18 (11.82), C19 (16.98), C25 (29.81), C26 (22.65), 
C27 (21.98). 
MS: m/z 478/480 (M+). 
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CHAPTCft-5 
jlntimicro6iaCjlctivity of 
Synthesized Compounds 
Theoretical 
Microorganisms are ubiquitously present in and around us. Almost all organisms are 
susceptible to infection by microorganisms that may cause pathogenic effects. The 
organisms are divided into many classes based on different parameters. Among these, 
vertebrates and invertebrates are very important. In these categories, the invertebrates 
defend themselves from infection without antibodies where as the lymphocytes are 
normally involved in the adaptive immunity of vertebrates to combat against the 
microorganisms. Antimicrobial peptides are one of the major weapons in the innate 
immunity response of invertebrates. These peptides are also found in vertebrates, plants 
and in bacteria.1 One of the major families of antimicrobial peptides that has been 
characterized is the defensins.2 Defensins are generally cationic antimicrobial peptides 
containing six disulphide paired cysteines, found highly effective against Gram-positive 
bacteria, and have potent activity against Gram-negative bacteria, fungi, yeast and 
protozoa.3 Although the vertebrates have the specific immune system but that may not be 
sufficient to combat with the microorganisms. Thus the usage of commercially available 
antibiotics like ampicillin, tetracycline, erythromycin, chloramphenicol etc. has increased 
besides some undesirable side effects. So the necessity to invent the alternative medicines 
is very much in demand which may not have the side effects. 
Development of resistance to existing drugs is constantly growing. Recent decline 
in the development of new drugs to combat infectious diseases has further increased the 
demand to synthesize new molecules with potential pharmacological properties. In view 
of the drug-resistant microorganisms, it is important that new drugs inhibit targets 
different from those of currently used drugs.4 In addition, development of new agents 
should also shorten the lengthy therapy, thus requires the design of drugs that can inhibit 
targets involved in persistence or dormancy. This can be achieved by either synthesis of 
analogues, modifications or derivatives of existing compounds for shortening and 
improving treatment or searching for novel structures that can be used against drug 
resistant microorganism. Steroidal derivatives have been found to be associated with 
diverse antimicrobial activities. 
Steroidal heterocycles containing the pyrazole (1), isoxazole (2). thiazole (3). 
p>rane (4), and pyridine ring (5) were also reported to be active against some bacteria and 
fungi." 
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(1) (2) 
I T /"" 
3
 ^C=N-NHCOCH3—<f 
N -.0 
0 NH2 
(3) 
(5) 
C27 steroidal saponins (6) and steroidal sapogenins (7) isolated from several 
monocotyledonous plants were found to be effective against a class of fungi. : 6 
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Glc(l-4)Fu—O 
, 0 . 
^Glc 
(6) 
GlcO 
OGlc 
(7) 
Saleem et al7 synthesized cholest-5-en-7-thiazolo [4, 5-b] quinoxaline-2-yl hydrazone 
derivatives (8-10) and reported them as promising antibacterial agents. 
X 
(8) H 
(9) AcO 
(10) CI 
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Saleem et al. reported the synthesis of different steroidal thiazolo quinoxaline (11-13) 
derivatives as antibacterial agents against E. coli. The antibacterial activities of these 
compounds were evaluated by disk diffusion method against the culture of E. coli and the 
results were compared with the standard drug amoxicillin. 
X 
(11) H 
(12) AcO 
(13) CI 
Stigmest-6-en-7, 5a thiourea (14-15) and stigmest-6-en-7, 5a urea (16-17) derivatives of 
steroids were found to be effective against a class of bacteria. 
C10H19 
X R 
(14) AcO S 
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(15) CI S 
(16) AcO O 
(17) CI O 
Several steroidal thiosemicarbazone derivatives (18) were also reported to be active 
against some bacteria. The antibacterial activity was first tested in vitro by the disk 
diffusion assay against two Gram-positive and two Gram-negative bacteria, and then the 
minimum inhibitory concentration (MIC) of compounds was determined.10 
C»Hi 
(18) 
The above pharmaceutical interest encouraged us to direct our research efforts for 
the synthesis of cholesterol derivatives and to report their in vitro antimicrobial 
properties. 
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(Discussion 
Steroidal pyrazolines 
The in vitro antibacterial activity of the synthesized compounds 114-116 was carried out 
against B. subtilis, S. Pyogenes, S. aureus, P. aeruginosa, K. pneumoniae and E. coli. 
Results of antibacterial screening are reported in Table 1. It was observed that compound 
114 showed promising results while the other two compounds showed moderate activity. 
Table 1. Antibacterial screening data for compounds 114-116. 
Compounds 
Strains 114 115 116 Positive Control 
MIC (fig/ml) 
32 32 
64 32 
32 32 
32 32 
32 32 
64 32 
Positive Control= Chloramphenicol 
Concentration used= 100 ug/ ml of DMSO 
BB. subtilis 64 16 
S. Pyogenes 128 64 
5. aureus 64 64 
P. aeruginosa 64 32 
S. typhimurium 64 64 
E.coli 128 64 
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Steroidal oxazoles 
The in vitro antibacterial activities of 2'-amino-5a-cholest-6-eno [6,5-d] oxazole 
derivatives 155-157 were tested using the bacterial cultures of B. subtilis, P. aeruginosa, 
S. aureus, S. pyogenes, S. typhimurium, E. coli and fungal cultures of Candida albicans, 
Candida glabrata, Penicillium spp., Fusarium oxyporium, Aspergillus niger by the disk 
diffusion method and subsequently the minimum inhibitory concentration (MIC) of all 
the compounds was determined. Chloramphenicol (30 ug) was used as the standard drug 
in case of bacteria and Nystatin was used as a standard drug in case of fungi, whereas the 
disk poured in DMSO was used as negative control. Compounds have cholestan skeleton 
with 3/?-acetoxy (156) and 3/?-chloro (157) substituents, respectively. The minimum 
inhibitory concentration (MIC) was assessed by the macro dilution test using standard 
inoculums of 105 CFU mL"1 Compounds were dissolved in dimethyl sulfoxide (DMSO) 
then serial dilutions of the test compounds were prepared to final concentrations of 512, 
256, 128, 64, 32, 16, 8, 4, 2 and 1 ug/ml to each tube was added 100 uL of a 24 h old 
inoculum. The MIC is the lowest concentration of the test compound, which can restrain 
the observable growth after 18 h incubation at 37 °C. The MIC was determined visually 
after incubation for 18 h, at 37 °C. The in vitro study results demonstrated that the 
compound 156 was found to be the most active among the three compounds. The zones 
of inhibition (mm) of every compound against Gram-positive and Gram-negative strains 
of bacteria are shown in Table 2. Zones of inhibition for fungal strains are shown in 
Table 3. MIC results for bacterial strains are shown in Table 4. 
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Steroidal mercapto diazoline 
These newly synthesized compounds (99-101) were evaluated in vitro against B. subtilis, 
P. aeruginosa and E. coli. From Table 5 it may be seen that compounds 99 and 101 
showed moderate activity against all the bacteria while the compound 100 showed good 
activity against these bacteria. It was observed that compounds exhibited enhanced activity 
on increasing the concentration from 100 |ig/ ml to 150 u.g/ ml. (Table 6). 
Table 5. Antibacterial screening data for compounds 99-101. 
Compounds 
Strains _99 100 101 
Diameter of zone of inhibition (mm) 
B. subtilis 12 15 17 
P. aeruginosa 23 25 13 
E. Coli 17 20 15 
Positive Control 22 24 22 
Concentration used= 100 ug/ ml of DMSO 
Table 6. Antibacterial screening data for compounds 99-101. 
Compounds 
Strains _99 100 101 
Diameter of zone of inhibition (mm) 
B. subtilis 19 22 25 
P. aeruginosa 28 31 18 
£ Coli 19 27 19 
Positive Control 31 32 32 
Positive Control= Chloramphenicol 
Concentration used= 150 ug/ ml of DMSO. 
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The varied divergence in the antimicrobial activity of these compounds validates 
the reason of this study. The importance of such work lies in the possibility that the new 
compounds might be more effective against bacteria for which a thorough investigation 
regarding the structure-activity relationship, toxicity and their biological effects which 
would be helpful in designing more potent antimicrobial agents for therapeutic use is 
required. 
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<ExperitnentaC 
The tested organisms used in the study included B. subtilis, P. aeruginosa, S. aureus, 
S. pyogenes, S. typhimurium, K. pneumoniae and E. coli and fungal cultures of Candida 
albicans, Candida glabrata, Penicillium spp., Fusarium oxyporium, Aspergillus niger 
were provided by Department of Biochemistry and Department of Microbiology, J. N. 
Medical College, A. M. U Aligarh, India. Nutrient broth and agar were obtained from Hi-
Media Pvt. Ltd. (Mumbai, India). 
Antibacterial activity of compounds 155-157 and 99-101. 
The in vitro antibacterial activity of steroidal pyrazolines 114-116 was carried out against 
B. subtilis, S. Pyogenes, S. aureus, P. aeruginosa, K. pneumoniae and E. coli. The in vitro 
antibacterial activities of 2'-amino-5a-cholest-6-eno [6,5-d] oxazole derivatives 155-157 
were tested using the bacterial cultures of B. subtilis, P. aeruginosa, S. aureus, S. 
pyogenes, S. typhimurium, E. coli and fungal cultures of Candida albicans, Candida 
glabrata, Penicillium spp., Fusarium oxyporium, Aspergillius niger, while steroidal 
mercapto diazoline (99-101) were evaluated in vitro against B. subtilis, P. aeruginosa and 
E. coli. 
These strains were streaked on nutrient agar plates separately and grown overnight. 
Single well isolated colonies of each type of bacteria were incubated in separate nutrient 
medium for 16 h at 37 °C for the experiment. To determine the zone of inhibition cup-plate 
method was employed." In this technique bacteria liquid culture of each type grown in log 
phase was added aseptically to the autoclaved LB agar medium maintained at 45 °C, mixed 
well and poured immediately into sterile Petri dishes separately. After solidification wells 
of about 6 mm were cut into agar plates aseptically. 
Solutions of 100|ag/ml 2'-amino-5a-cholest-6-eno [6,5-d] oxazole derivatives 155-
157 and lOOug/mi and 150ug/ml steroidal mercapto diazoline (99-101) were prepared in 
DMSO. Standard antibiotic Chloromycetin was screened under similar conditions. lOOul of 
these solutions were added to each well and incubated at 37 °C. One of the wells was used 
as control by adding lOOug/ml of DMSO. Zone of inhibition was measured in mm after 24 
h and compared with standard drug. Results of antibacterial screening are reported in Table 
2, 5 and 6. 
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Antimicrobial activity of compounds 114-116 and 155-157 
Antibacterial activity of the synthesized compounds was completed by the disk diffusion 
method with slight modifications.8 Inoculums of B. sabtilis, P. aeruginosa, S. aureus, 
S. pyogenes, S. typhimurium, K. pneumoniae and E. coli were prepared in Brain Heart 
Infusion medium and incubated for 18 h at 37 °C. Subsequently a suspension of about 10 
CFU/mL was prepared in autoclaved saline solution according to the McFarland protocol. 
Then 10 ul of this saline suspension was mixed with 10 mL of sterile antibiotic agar at 40 °C 
and plates were poured under aseptic conditions. Five paper disks of 6.0 mm diameter were 
placed on these nutrient agar plates. One mg of each test compound was dissolved in 100 ul 
dimethyl sulphoxide (DMSO) to get ready stock solution and from this stock solution varied 
concentrations 10, 20, 25, 50, and 100 mg/ L of all trial compounds were set. Subsequently 
the compounds of varied concentrations were poured over disk plate on to it. The disk of 
Chloramphenicol (30u.g) was used as a positive control and DMSO poured disk as a 
negative control. The susceptibility was assessed on the basis of diameter of zone of 
inhibition against Gram-positive and Gram-negative strains of bacteria and fungi. The macro 
dilution test with standard inoculums of 105 CFU/mL was used to assess the minimum 
inhibitory concentration (MIC) of test compounds (Table 1 and 4). The DMSO was made to 
dissolve the compounds. Serial dilutions of the compounds were prepared to the final 
concentrations of 512, 256, 128, 64, 32, 16, 8, 4, 2 and 1 |ig/mL. These tubes were kept at 37 
°C for 18 h. For assaying antifungal activity Candida albicans, Candida glabrata, 
Penicillium spp., Fusarium oxyporium, Aspergillus niger were inoculated in Sabouraud 
Dextrose broth medium (Hi-Media Mumbai) and incubated for 24 h at 35 °C, and 
subsequently a suspension of about 106 CFU/mL was prepared in sterile saline solution 
according to the McFarland protocol. Sabouraud Dextrose Agar (SDA) plates were streaked 
using sterilized cotton swabs of each fungal cell. Five paper disks of 6.0 mm diameter were 
put onto Sabouraud Dextrose agar plate. 1 mg of each test compound was dissolved in 100 
ul DMSO to get ready stock solution and from this stock solution varied concentrations 10, 
20, 25, 50, and 100 (xg/uL of all trial compounds were set. Subsequently the compounds of 
varied concentrations were poured over disk plate on to it. The disk of Nystetin (30p.g) was 
used as a positive control and disk of DMSO used as a negative control. The susceptibility 
of different fungal strains against test compounds was assessed on the basis of diameter of 
zone of inhibition after 48 h of incubation at 35 °C. 
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